BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA. 1999;96:10911-10916. [PMID: 10485925 DOI: 10.1073/pnas.96.19.10911] [Cited by in Crossref: 834] [Cited by in F6Publishing: 803] [Article Influence: 36.3] [Reference Citation Analysis]
Number Citing Articles
1 Cai J, Cooke FE, Sherborne BS. Antagonists of the orexin receptors. Expert Opinion on Therapeutic Patents 2006;16:631-46. [DOI: 10.1517/13543776.16.5.631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Bazar KA, Yun A, Lee PY. Debunking a myth: neurohormonal and vagal modulation of sleep centers, not redistribution of blood flow, may account for postprandial somnolence. Medical Hypotheses 2004;63:778-82. [DOI: 10.1016/j.mehy.2004.04.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
3 Al-Barazanji KA, Wilson S, Baker J, Jessop DS, Harbuz MS. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J Neuroendocrinol 2001;13:421-4. [PMID: 11328451 DOI: 10.1046/j.1365-2826.2001.00655.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 4.4] [Reference Citation Analysis]
4 Carter ME, Brill J, Bonnavion P, Huguenard JR, Huerta R, de Lecea L. Mechanism for Hypocretin-mediated sleep-to-wake transitions. Proc Natl Acad Sci U S A 2012;109:E2635-44. [PMID: 22955882 DOI: 10.1073/pnas.1202526109] [Cited by in Crossref: 151] [Cited by in F6Publishing: 140] [Article Influence: 15.1] [Reference Citation Analysis]
5 Liu ZB, Song NN, Geng WY, Jin WZ, Li L, Cao YX, Qian Y, Zhu DN, Shen LL. Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease. Clin Exp Pharmacol Physiol 2010;37:963-8. [PMID: 20528981 DOI: 10.1111/j.1440-1681.2010.05411.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
6 Roman A, Meftah S, Arthaud S, Luppi P, Peyron C. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep. Sleep 2018;41. [DOI: 10.1093/sleep/zsy046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
7 Dye TJ, Gurbani N, Simakajornboon N. Epidemiology and Pathophysiology of Childhood Narcolepsy. Paediatr Respir Rev 2018;25:14-8. [PMID: 28108192 DOI: 10.1016/j.prrv.2016.12.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
8 Satoh S, Matsumura H, Nakajima T, Nakahama K, Kanbayashi T, Nishino S, Yoneda H, Shigeyoshi Y. Inhibition of rostral basal forebrain neurons promotes wakefulness and induces FOS in orexin neurons. Eur J Neurosci 2003;17:1635-45. [PMID: 12752381 DOI: 10.1046/j.1460-9568.2003.02577.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
9 Desarnaud F, Murillo-Rodriguez E, Lin L, Xu M, Gerashchenko D, Shiromani SN, Nishino S, Mignot E, Shiromani PJ. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 2004;27:851-6. [PMID: 15453542 DOI: 10.1093/sleep/27.5.851] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
10 Russell SH, Small CJ, Sunter D, Morgan I, Dakin CL, Cohen MA, Bloom SR. Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue. Regul Pept 2002;104:61-8. [PMID: 11830278 DOI: 10.1016/s0167-0115(01)00349-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
11 Ida T, Nakahara K, Murakami T, Hanada R, Nakazato M, Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 2000;270:318-23. [PMID: 10733946 DOI: 10.1006/bbrc.2000.2412] [Cited by in Crossref: 198] [Cited by in F6Publishing: 191] [Article Influence: 9.0] [Reference Citation Analysis]
12 Fulong X, Spruyt K, Chao L, Dianjiang Z, Jun Z, Fang H. Resting-state brain network topological properties and the correlation with neuropsychological assessment in adolescent narcolepsy. Sleep 2020;43:zsaa018. [DOI: 10.1093/sleep/zsaa018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Sunter D, Morgan I, Edwards CM, Dakin CL, Murphy KG, Gardiner J, Taheri S, Rayes E, Bloom SR. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res 2001;907:27-34. [PMID: 11430882 DOI: 10.1016/s0006-8993(01)02344-7] [Cited by in Crossref: 43] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Donjacour CE, Aziz NA, Roelfsema F, Frölich M, Overeem S, Lammers GJ, Pijl H. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls. Am J Physiol Endocrinol Metab 2011;300:E1069-75. [PMID: 21447786 DOI: 10.1152/ajpendo.00623.2010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
15 Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, Arch JR. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 1999;20:1099-105. [DOI: 10.1016/s0196-9781(99)00105-9] [Cited by in Crossref: 226] [Cited by in F6Publishing: 54] [Article Influence: 9.8] [Reference Citation Analysis]
16 Hoang QV, Zhao P, Nakajima S, Nakajima Y. Orexin (hypocretin) effects on constitutively active inward rectifier K+ channels in cultured nucleus basalis neurons. J Neurophysiol 2004;92:3183-91. [PMID: 15269229 DOI: 10.1152/jn.01222.2003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
17 Jászberényi M, Bujdosó E, Pataki I, Telegdy G. Effects of orexins on the hypothalamic-pituitary-adrenal system. J Neuroendocrinol 2000;12:1174-8. [PMID: 11106974 DOI: 10.1046/j.1365-2826.2000.00572.x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 132] [Article Influence: 6.0] [Reference Citation Analysis]
18 Neylan TC, Richards A, Metzler TJ, Ruoff LM, Varbel J, O'Donovan A, Sivasubramanian M, Motraghi T, Hlavin J, Batki SL, Inslicht SS, Samuelson K, Morairty SR, Kilduff TS. Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial. Sleep 2020;43:zsaa080. [PMID: 32303763 DOI: 10.1093/sleep/zsaa080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Fakhari M, Azizi H, Semnanian S. Central antagonism of orexin type-1 receptors attenuates the development of morphine dependence in rat locus coeruleus neurons. Neuroscience 2017;363:1-10. [DOI: 10.1016/j.neuroscience.2017.08.054] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
20 Han F. Narcolepsy, orexins and respiratory regulation: Respiratory regulation in narcolepsy. Sleep and Biological Rhythms 2011;9:44-51. [DOI: 10.1111/j.1479-8425.2010.00467.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Vyse TJ. Narcolepsy and the T-cell receptor. Nat Genet 2009;41:640-1. [PMID: 19471301 DOI: 10.1038/ng0609-640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Guan JL, Suzuki R, Funahashi H, Wang QP, Kageyama H, Uehara K, Yamada S, Tsurugano S, Shioda S. Ultrastructural localization of orexin-1 receptor in pre- and post-synaptic neurons in the rat arcuate nucleus. Neurosci Lett 2002;329:209-12. [PMID: 12165414 DOI: 10.1016/s0304-3940(02)00660-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
23 Tyree SM, Borniger JC, de Lecea L. Hypocretin as a Hub for Arousal and Motivation. Front Neurol 2018;9:413. [PMID: 29928253 DOI: 10.3389/fneur.2018.00413] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
24 Ouyang M, Hellman K, Abel T, Thomas SA. Adrenergic signaling plays a critical role in the maintenance of waking and in the regulation of REM sleep. J Neurophysiol 2004;92:2071-82. [PMID: 15190089 DOI: 10.1152/jn.00226.2004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 3.7] [Reference Citation Analysis]
25 Downs JL, Dunn MR, Borok E, Shanabrough M, Horvath TL, Kohama SG, Urbanski HF. Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque. Neurobiol Aging 2007;28:1286-95. [PMID: 16870307 DOI: 10.1016/j.neurobiolaging.2006.05.025] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.6] [Reference Citation Analysis]
26 Sinton CM. Orexin/hypocretin plays a role in the response to physiological disequilibrium. Sleep Med Rev 2011;15:197-207. [PMID: 21269851 DOI: 10.1016/j.smrv.2010.12.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
27 Szabadi E. Functional neuroanatomy of the central noradrenergic system. J Psychopharmacol. 2013;27:659-693. [PMID: 23761387 DOI: 10.1177/0269881113490326] [Cited by in Crossref: 167] [Cited by in F6Publishing: 152] [Article Influence: 18.6] [Reference Citation Analysis]
28 Kumar A, Chanana P, Choudhary S. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs. Pharmacological Reports 2016;68:231-42. [DOI: 10.1016/j.pharep.2015.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
29 Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Electrophysiological effects of orexins/hypocretins on pedunculopontine tegmental neurons in rats: an in vitro study. Peptides 2009;30:191-209. [PMID: 18977258 DOI: 10.1016/j.peptides.2008.09.023] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
30 Kushikata T, Hirota K, Yoshida H, Kudo M, Lambert DG, Smart D, Jerman JC, Matsuki A. Orexinergic neurons and barbiturate anesthesia. Neuroscience 2003;121:855-63. [PMID: 14580935 DOI: 10.1016/s0306-4522(03)00554-2] [Cited by in Crossref: 63] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
31 Taheri S, Gardiner J, Hafizi S, Murphy K, Dakin C, Seal L, Small C, Ghatei M, Bloom S. Orexin A immunoreactivity and prepro-orexin mRNA in the brain of Zucker and WKY rats: . Neuroreport 2001;12:459-64. [DOI: 10.1097/00001756-200103050-00008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
32 Jiménez A, Caba M, Escobar C. Food-entrained patterns in orexin cells reveal subregion differential activation. Brain Research 2013;1513:41-50. [DOI: 10.1016/j.brainres.2013.03.031] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
33 Eisinger BE, Zhao C, Driessen TM, Saul MC, Gammie SC. Large scale expression changes of genes related to neuronal signaling and developmental processes found in lateral septum of postpartum outbred mice. PLoS One 2013;8:e63824. [PMID: 23717492 DOI: 10.1371/journal.pone.0063824] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
34 Dhillo WS. Appetite Regulation: An Overview. Thyroid 2007;17:433-45. [DOI: 10.1089/thy.2007.0018] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 5.1] [Reference Citation Analysis]
35 Hoffmann J, Supronsinchai W, Akerman S, Andreou AP, Winrow CJ, Renger J, Hargreaves R, Goadsby PJ. Evidence for orexinergic mechanisms in migraine. Neurobiology of Disease 2015;74:137-43. [DOI: 10.1016/j.nbd.2014.10.022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 7.1] [Reference Citation Analysis]
36 Ishii Y, Blundell JE, Halford JC, Upton N, Porter R, Johns A, Rodgers RJ. Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S. Behav Brain Res 2005;160:11-24. [PMID: 15836896 DOI: 10.1016/j.bbr.2004.11.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.7] [Reference Citation Analysis]
37 Deporter DP, Coborn JE, Teske JA. Partial Sleep Deprivation Reduces the Efficacy of Orexin-A to Stimulate Physical Activity and Energy Expenditure: Sleep Deprivation Dampens EE During Physical Activity. Obesity 2017;25:1716-22. [DOI: 10.1002/oby.21944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
38 Kohlmeier KA, Watanabe S, Tyler CJ, Burlet S, Leonard CS. Dual orexin actions on dorsal raphe and laterodorsal tegmentum neurons: noisy cation current activation and selective enhancement of Ca2+ transients mediated by L-type calcium channels. J Neurophysiol 2008;100:2265-81. [PMID: 18667550 DOI: 10.1152/jn.01388.2007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 65] [Article Influence: 4.2] [Reference Citation Analysis]
39 Fernø J, Señarís R, Diéguez C, Tena-Sempere M, López M. Orexins (hypocretins) and energy balance: More than feeding. Mol Cell Endocrinol 2015;418 Pt 1:17-26. [PMID: 26213323 DOI: 10.1016/j.mce.2015.07.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
40 Acuna-Goycolea C, van den Pol AN. Neuroendocrine proopiomelanocortin neurons are excited by hypocretin/orexin. J Neurosci 2009;29:1503-13. [PMID: 19193897 DOI: 10.1523/JNEUROSCI.5147-08.2009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
41 Soffin EM, Evans ML, Gill CH, Harries MH, Benham CD, Davies CH. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology 2002;42:127-33. [PMID: 11750922 DOI: 10.1016/s0028-3908(01)00156-3] [Cited by in Crossref: 65] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
42 Morales A, Bonnet C, Bourgoin N, Touvier T, Nadam J, Laglaine A, Navarro F, Moulin C, Georges B, Pequignot JM, Bezin L. Unexpected expression of orexin-B in basal conditions and increased levels in the adult rat hippocampus during pilocarpine-induced epileptogenesis. Brain Res 2006;1109:164-75. [PMID: 16904080 DOI: 10.1016/j.brainres.2006.06.075] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
43 Flores Á, Julià-Hernández M, Maldonado R, Berrendero F. Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ(9) -tetrahydrocannabinol. Br J Pharmacol 2016;173:1381-92. [PMID: 26799708 DOI: 10.1111/bph.13440] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
44 Li JX, Yoshida T, Monk KJ, Katz DB. Lateral hypothalamus contains two types of palatability-related taste responses with distinct dynamics. J Neurosci 2013;33:9462-73. [PMID: 23719813 DOI: 10.1523/JNEUROSCI.3935-12.2013] [Cited by in Crossref: 41] [Article Influence: 4.6] [Reference Citation Analysis]
45 Vogel V, Sanchez C, Jennum P. EEG measurements by means of radiotelemetry after intracerebroventricular (ICV) cannulation in rodents. Journal of Neuroscience Methods 2002;118:89-96. [DOI: 10.1016/s0165-0270(02)00148-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
46 Semba K. Multiple output pathways of the basal forebrain: organization, chemical heterogeneity, and roles in vigilance. Behavioural Brain Research 2000;115:117-41. [DOI: 10.1016/s0166-4328(00)00254-0] [Cited by in Crossref: 178] [Cited by in F6Publishing: 62] [Article Influence: 8.1] [Reference Citation Analysis]
47 Equihua AC, De La Herrán-Arita AK, Drucker-Colin R. Orexin receptor antagonists as therapeutic agents for insomnia. Front Pharmacol 2013;4:163. [PMID: 24416019 DOI: 10.3389/fphar.2013.00163] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
48 Rusyniak DE, Zaretsky DV, Zaretskaia MV, Durant PJ, DiMicco JA. The orexin-1 receptor antagonist SB-334867 decreases sympathetic responses to a moderate dose of methamphetamine and stress. Physiol Behav 2012;107:743-50. [PMID: 22361264 DOI: 10.1016/j.physbeh.2012.02.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
49 Hou RH, Freeman C, Langley RW, Szabadi E, Bradshaw CM. Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. Psychopharmacology 2005;181:537-49. [DOI: 10.1007/s00213-005-0013-8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 81] [Article Influence: 4.8] [Reference Citation Analysis]
50 Carter ME, Adamantidis A, Ohtsu H, Deisseroth K, de Lecea L. Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J Neurosci 2009;29:10939-49. [PMID: 19726652 DOI: 10.1523/JNEUROSCI.1205-09.2009] [Cited by in Crossref: 155] [Cited by in F6Publishing: 89] [Article Influence: 11.9] [Reference Citation Analysis]
51 Su J, Lei Z, Zhang W, Ning H, Ping J. Distribution of orexin B and its relationship with GnRH in the pig hypothalamus. Res Vet Sci 2008;85:315-23. [PMID: 18255106 DOI: 10.1016/j.rvsc.2007.12.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
52 Aracri P, Banfi D, Pasini ME, Amadeo A, Becchetti A. Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex. Cereb Cortex 2015;25:1330-47. [PMID: 24297328 DOI: 10.1093/cercor/bht326] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
53 Boss C, Roch-brisbare C, Steiner MA, Treiber A, Dietrich H, Jenck F, von Raumer M, Sifferlen T, Brotschi C, Heidmann B, Williams JT, Aissaoui H, Siegrist R, Gatfield J. Structure-Activity Relationship, Biological, and Pharmacological Characterization of the Proline Sulfonamide ACT-462206: a Potent, Brain-Penetrant Dual Orexin 1/Orexin 2 Receptor Antagonist. ChemMedChem 2014;9:2486-96. [DOI: 10.1002/cmdc.201402258] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
54 He C, Chen QH, Ye JN, Li C, Yang L, Zhang J, Xia JX, Hu ZA. Functional inactivation of hypocretin 1 receptors in the medial prefrontal cortex affects the pyramidal neuron activity and gamma oscillations: An in vivo multiple-channel single-unit recording study. Neuroscience 2015;297:1-10. [PMID: 25838117 DOI: 10.1016/j.neuroscience.2015.03.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
55 Rosin DL, Weston MC, Sevigny CP, Stornetta RL, Guyenet PG. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 2003;465:593-603. [PMID: 12975818 DOI: 10.1002/cne.10860] [Cited by in Crossref: 166] [Cited by in F6Publishing: 170] [Article Influence: 8.7] [Reference Citation Analysis]
56 Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001;18:78-105. [PMID: 11435802 DOI: 10.1097/00004691-200103000-00002] [Cited by in Crossref: 217] [Cited by in F6Publishing: 164] [Article Influence: 10.3] [Reference Citation Analysis]
57 Zhang T, Jiang X, Xu M, Wang H, Sang X, Qin M, Bao P, Wang R, Zhang C, Lu H, Li Y, Ren J, Chang HC, Yan J, Sun Q, Xu J. Sleep and circadian abnormalities precede cognitive deficits in R521C FUS knockin rats. Neurobiol Aging 2018;72:159-70. [PMID: 30273830 DOI: 10.1016/j.neurobiolaging.2018.08.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
58 Sargin D. The role of the orexin system in stress response. Neuropharmacology 2019;154:68-78. [PMID: 30266600 DOI: 10.1016/j.neuropharm.2018.09.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
59 Arrigoni E, Mochizuki T, Scammell TE. Activation of the basal forebrain by the orexin/hypocretin neurones. Acta Physiol (Oxf) 2010;198:223-35. [PMID: 19723027 DOI: 10.1111/j.1748-1716.2009.02036.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.5] [Reference Citation Analysis]
60 Orlowska-Feuer P, Smyk MK, Palus-Chramiec K, Dyl K, Lewandowski MH. Orexin A as a modulator of dorsal lateral geniculate neuronal activity: a comprehensive electrophysiological study on adult rats. Sci Rep 2019;9:16729. [PMID: 31723155 DOI: 10.1038/s41598-019-53012-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
61 Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, Akaoka H, Sergeeva OA, Yanagisawa M, Ohtsu H, Franco P, Haas HL, Lin JS. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009;29:14423-38. [PMID: 19923277 DOI: 10.1523/JNEUROSCI.2604-09.2009] [Cited by in Crossref: 131] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
62 Galvão MDOL, Sinigaglia-coimbra R, Kawakami SE, Tufik S, Suchecki D. Paradoxical sleep deprivation activates hypothalamic nuclei that regulate food intake and stress response. Psychoneuroendocrinology 2009;34:1176-83. [DOI: 10.1016/j.psyneuen.2009.03.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
63 Prince CD, Rau AR, Yorgason JT, España RA. Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1. ACS Chem Neurosci 2015;6:138-46. [PMID: 25496218 DOI: 10.1021/cn500246j] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 6.9] [Reference Citation Analysis]
64 Nishino S. Narcolepsy. Sleep Medicine Clinics 2006;1:47-61. [DOI: 10.1016/j.jsmc.2005.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Yaeger JD, Krupp KT, Gale JJ, Summers CH. Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery 2020;8:100059. [DOI: 10.1016/j.medidd.2020.100059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol. 2009;53:120-128. [PMID: 19466203 DOI: 10.1590/S0004-27302009000200002] [Cited by in Crossref: 77] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
67 Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008;199:109-17. [PMID: 18470506 DOI: 10.1007/s00213-008-1136-5] [Cited by in Crossref: 166] [Cited by in F6Publishing: 178] [Article Influence: 11.9] [Reference Citation Analysis]
68 Perez-Leighton CE, Butterick-Peterson TA, Billington CJ, Kotz CM. Role of orexin receptors in obesity: from cellular to behavioral evidence. Int J Obes (Lond) 2013;37:167-74. [PMID: 22391883 DOI: 10.1038/ijo.2012.30] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
69 Prud'homme MJ, Lacroix MC, Badonnel K, Gougis S, Baly C, Salesse R, Caillol M. Nutritional status modulates behavioural and olfactory bulb Fos responses to isoamyl acetate or food odour in rats: roles of orexins and leptin. Neuroscience 2009;162:1287-98. [PMID: 19477242 DOI: 10.1016/j.neuroscience.2009.05.043] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 4.3] [Reference Citation Analysis]
70 Samson WK, Resch ZT. The hypocretin/orexin story. Trends Endocrinol Metab 2000;11:257-62. [PMID: 10920381 DOI: 10.1016/s1043-2760(00)00273-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
71 Naylor E, Aillon DV, Gabbert S, Harmon H, Johnson DA, Wilson GS, Petillo PA. Simultaneous real-time measurement of EEG/EMG and L-glutamate in mice: A biosensor study of neuronal activity during sleep. J Electroanal Chem (Lausanne) 2011;656:106-13. [PMID: 27076812 DOI: 10.1016/j.jelechem.2010.12.031] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
72 Burdakov D. Reactive and predictive homeostasis: Roles of orexin/hypocretin neurons. Neuropharmacology 2019;154:61-7. [PMID: 30347195 DOI: 10.1016/j.neuropharm.2018.10.024] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
73 Reinscheid RK, Xu Y. Neuropeptide S and Its Receptor: A Newly Deorphanized G Protein–Coupled Receptor System. Neuroscientist 2005;11:532-8. [DOI: 10.1177/1073858405276405] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 5.7] [Reference Citation Analysis]
74 van den Top M, Nolan MF, Lee K, Richardson PJ, Buijs RM, Davies CH, Spanswick D. Orexins induce increased excitability and synchronisation of rat sympathetic preganglionic neurones. J Physiol. 2003;549:809-821. [PMID: 12702746 DOI: 10.1113/jphysiol.2002.033290] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 4.1] [Reference Citation Analysis]
75 Revel FG, Gottowik J, Gatti S, Wettstein JG, Moreau J. Rodent models of insomnia: A review of experimental procedures that induce sleep disturbances. Neuroscience & Biobehavioral Reviews 2009;33:874-99. [DOI: 10.1016/j.neubiorev.2009.03.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
76 Schreyer S, Büttner-Ennever JA, Tang X, Mustari MJ, Horn AK. Orexin-A inputs onto visuomotor cell groups in the monkey brainstem. Neuroscience 2009;164:629-40. [PMID: 19703526 DOI: 10.1016/j.neuroscience.2009.08.039] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
77 Burlet S, Tyler CJ, Leonard CS. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 2002;22:2862-72. [PMID: 11923451 DOI: 20026234] [Cited by in Crossref: 184] [Article Influence: 9.2] [Reference Citation Analysis]
78 Grafe LA, Eacret D, Luz S, Gotter AL, Renger JJ, Winrow CJ, Bhatnagar S. Orexin 2 receptor regulation of the hypothalamic-pituitary-adrenal (HPA) response to acute and repeated stress. Neuroscience 2017;348:313-23. [PMID: 28257896 DOI: 10.1016/j.neuroscience.2017.02.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
79 Hunt NJ, Waters KA, Rodriguez ML, Machaalani R. Decreased orexin (hypocretin) immunoreactivity in the hypothalamus and pontine nuclei in sudden infant death syndrome. Acta Neuropathol 2015;130:185-98. [PMID: 25953524 DOI: 10.1007/s00401-015-1437-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
80 Gotter AL, Winrow CJ, Brunner J, Garson SL, Fox SV, Binns J, Harrell CM, Cui D, Yee KL, Stiteler M, Stevens J, Savitz A, Tannenbaum PL, Tye SJ, McDonald T, Yao L, Kuduk SD, Uslaner J, Coleman PJ, Renger JJ. The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold. BMC Neurosci 2013;14:90. [PMID: 23981345 DOI: 10.1186/1471-2202-14-90] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
81 España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep 2011;34:845-58. [PMID: 21731134 DOI: 10.5665/SLEEP.1112] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
82 Cajochen C, Wyatt JK, Czeisler CA, Dijk DJ. Separation of circadian and wake duration-dependent modulation of EEG activation during wakefulness. Neuroscience 2002;114:1047-60. [PMID: 12379258 DOI: 10.1016/s0306-4522(02)00209-9] [Cited by in Crossref: 120] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
83 Ito N, Yabe T, Gamo Y, Nagai T, Oikawa T, Yamada H, Hanawa T. I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation. Neuroscience 2008;157:720-32. [DOI: 10.1016/j.neuroscience.2008.09.042] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
84 Hervieu G, Cluderay J, Harrison D, Roberts J, Leslie R. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001;103:777-97. [DOI: 10.1016/s0306-4522(01)00033-1] [Cited by in Crossref: 340] [Cited by in F6Publishing: 109] [Article Influence: 16.2] [Reference Citation Analysis]
85 Tkacs NC, Pan Y, Sawhney G, Mann GL, Morrison AR. Hypoglycemia activates arousal-related neurons and increases wake time in adult rats. Physiol Behav 2007;91:240-9. [PMID: 17434543 DOI: 10.1016/j.physbeh.2007.03.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
86 Majid H, Hirshkowitz M. Therapeutics of Narcolepsy. Sleep Medicine Clinics 2010;5:659-73. [DOI: 10.1016/j.jsmc.2010.08.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
87 Helena C, Gustafsson JA, Korach K, Pfaff D, Anselmo-Franci JA, Ogawa S. Effects of estrogen receptor alpha and beta gene deletion on estrogenic induction of progesterone receptors in the locus coeruleus in female mice. Endocrine 2009;36:169-77. [PMID: 19551522 DOI: 10.1007/s12020-009-9207-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
88 Shirasaka T, Kunitake T, Takasaki M, Kannan H. Neuronal effects of orexins: relevant to sympathetic and cardiovascular functions. Regul Pept 2002;104:91-5. [PMID: 11830282 DOI: 10.1016/s0167-0115(01)00352-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
89 Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Blundell JE. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept. 2000;96:71-84. [PMID: 11102655 DOI: 10.1016/S0167-0115(00)00203-2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
90 Galas L, Vaudry H, Braun B, Van Den Pol AN, De Lecea L, Sutcliffe JG, Chartrel N. Immunohistochemical localization and biochemical characterization of hypocretin/orexin-related peptides in the central nervous system of the frogRana ridibunda. J Comp Neurol 2001;429:242-52. [DOI: 10.1002/1096-9861(20000108)429:2<242::aid-cne5>3.0.co;2-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
91 Murai Y, Akaike T. Orexins cause depolarization via nonselective cationic and K+ channels in isolated locus coeruleus neurons. Neuroscience Research 2005;51:55-65. [DOI: 10.1016/j.neures.2004.09.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
92 James MH, Campbell EJ, Dayas CV. Role of the Orexin/Hypocretin System in Stress-Related Psychiatric Disorders. Curr Top Behav Neurosci 2017;33:197-219. [PMID: 28083790 DOI: 10.1007/7854_2016_56] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 11.0] [Reference Citation Analysis]
93 Selbach O, Doreulee N, Bohla C, Eriksson KS, Sergeeva OA, Poelchen W, Brown RE, Haas HL. Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling. Neuroscience 2004;127:519-28. [PMID: 15262340 DOI: 10.1016/j.neuroscience.2004.05.012] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 4.7] [Reference Citation Analysis]
94 Papolos D, Mattis S, Golshan S, Molay F. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes. J Affect Disord 2009;118:28-38. [PMID: 19631388 DOI: 10.1016/j.jad.2009.06.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
95 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Res 2010;1314:91-102. [PMID: 19748490 DOI: 10.1016/j.brainres.2009.09.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
96 Mieda M, Williams SC, Sinton CM, Richardson JA, Sakurai T, Yanagisawa M. Orexin neurons function in an efferent pathway of a food-entrainable circadian oscillator in eliciting food-anticipatory activity and wakefulness. J Neurosci 2004;24:10493-501. [PMID: 15548664 DOI: 10.1523/JNEUROSCI.3171-04.2004] [Cited by in Crossref: 151] [Cited by in F6Publishing: 63] [Article Influence: 8.9] [Reference Citation Analysis]
97 Smith PM, Samson WK, Ferguson AV. Cardiovascular actions of orexin-A in the rat subfornical organ. J Neuroendocrinol 2007;19:7-13. [PMID: 17184481 DOI: 10.1111/j.1365-2826.2006.01497.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
98 Szentirmai É, Kapás L. Nicotinic acid promotes sleep through prostaglandin synthesis in mice. Sci Rep 2019;9:17084. [PMID: 31745228 DOI: 10.1038/s41598-019-53648-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Mcgranaghan PA, Piggins HD. Orexin A-like immunoreactivity in the hypothalamus and thalamus of the Syrian hamster (Mesocricetus auratus) and Siberian hamster (Phodopus sungorus), with special reference to circadian structures. Brain Research 2001;904:234-44. [DOI: 10.1016/s0006-8993(01)02463-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
100 Korotkova TM, Sergeeva OA, Ponomarenko AA, Haas HL. Histamine excites noradrenergic neurons in locus coeruleus in rats. Neuropharmacology 2005;49:129-34. [DOI: 10.1016/j.neuropharm.2005.03.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
101 Sharma R, Sahota P, Thakkar MM. Role of adenosine and the orexinergic perifornical hypothalamus in sleep-promoting effects of ethanol. Sleep 2014;37:525-33. [PMID: 24587575 DOI: 10.5665/sleep.3490] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
102 Deng F, Zhang Y, Zhang R, Tang Q, Guo Z, Lv Y, Wang Z, Yang Y. Compromised Dynamic Cerebral Autoregulation in Patients With Central Disorders of Hypersomnolence. Front Neurol 2021;12:634660. [PMID: 33776891 DOI: 10.3389/fneur.2021.634660] [Reference Citation Analysis]
103 Aghajani N, Pourhamzeh M, Azizi H, Semnanian S. Central blockade of orexin type 1 receptors reduces naloxone induced activation of locus coeruleus neurons in morphine dependent rats. Neurosci Lett 2021;755:135909. [PMID: 33892002 DOI: 10.1016/j.neulet.2021.135909] [Reference Citation Analysis]
104 Hagan JJ, Price GW, Jeffrey P, Deeks NJ, Stean T, Piper D, Smith MI, Upton N, Medhurst AD, Middlemiss DN, Riley GJ, Lovell PJ, Bromidge SM, Thomas DR. Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol 2000;130:539-48. [PMID: 10821781 DOI: 10.1038/sj.bjp.0703357] [Cited by in Crossref: 216] [Cited by in F6Publishing: 220] [Article Influence: 9.8] [Reference Citation Analysis]
105 Selbach O, Haas HL. Hypocretins: The Timing of Sleep and Waking. Chronobiology International 2009;23:63-70. [DOI: 10.1080/07420520500545961] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
106 Latifi B, Adamantidis A, Bassetti C, Schmidt MH. Sleep-Wake Cycling and Energy Conservation: Role of Hypocretin and the Lateral Hypothalamus in Dynamic State-Dependent Resource Optimization. Front Neurol 2018;9:790. [PMID: 30344503 DOI: 10.3389/fneur.2018.00790] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
107 Szentirmai E, Kapás L, Sun Y, Smith RG, Krueger JM. Spontaneous sleep and homeostatic sleep regulation in ghrelin knockout mice. Am J Physiol Regul Integr Comp Physiol 2007;293:R510-7. [PMID: 17409264 DOI: 10.1152/ajpregu.00155.2007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
108 Fujiki N, Yoshida Y, Zhang S, Sakurai T, Yanagisawa M, Nishino S. Sex difference in body weight gain and leptin signaling in hypocretin/orexin deficient mouse models. Peptides 2006;27:2326-31. [PMID: 16626839 DOI: 10.1016/j.peptides.2006.03.011] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
109 Taheri S, Bloom S. Orexins/hypocretins: waking up the scientific world: Orexins and hypocretins. Clinical Endocrinology 2001;54:421-9. [DOI: 10.1046/j.1365-2265.2001.01247.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
110 Teske J, Billington C, Kotz C. Neuropeptidergic Mediators of Spontaneous Physical Activity and Non-Exercise Activity Thermogenesis. Neuroendocrinology 2008;87:71-90. [DOI: 10.1159/000110802] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
111 Davimes JG, Alagaili AN, Bennett NC, Mohammed OB, Bhagwandin A, Manger PR, Gravett N. Neurochemical organization and morphology of the sleep related nuclei in the brain of the Arabian oryx, Oryx leucoryx. J Chem Neuroanat 2017;81:53-70. [PMID: 28163217 DOI: 10.1016/j.jchemneu.2017.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
112 Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: orexins and neuromedins. Handb Exp Pharmacol 2012;:77-109. [PMID: 22249811 DOI: 10.1007/978-3-642-24716-3_4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
113 Domínguez L, Morona R, Joven A, González A, López JM. Immunohistochemical localization of orexins (hypocretins) in the brain of reptiles and its relation to monoaminergic systems. Journal of Chemical Neuroanatomy 2010;39:20-34. [DOI: 10.1016/j.jchemneu.2009.07.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
114 Burdakov D, Alexopoulos H. Metabolic state signalling through central hypocretin/orexin neurons. J Cell Mol Med 2005;9:795-803. [PMID: 16364191 DOI: 10.1111/j.1582-4934.2005.tb00380.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
115 Bårdsen K, Gjerstad MD, Partinen M, Kvivik I, Tjensvoll AB, Ruoff P, Omdal R, Brede C. Considerably Lower Levels of Hypocretin-1 in Cerebrospinal Fluid Is Revealed by a Novel Mass Spectrometry Method Compared with Standard Radioimmunoassay. Anal Chem 2019;91:9323-9. [DOI: 10.1021/acs.analchem.9b02710] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
116 Szentirmai E, Kapás L, Krueger JM. Ghrelin microinjection into forebrain sites induces wakefulness and feeding in rats. Am J Physiol Regul Integr Comp Physiol 2007;292:R575-85. [PMID: 16917015 DOI: 10.1152/ajpregu.00448.2006] [Cited by in Crossref: 84] [Cited by in F6Publishing: 85] [Article Influence: 5.3] [Reference Citation Analysis]
117 Finke JB, Deuter CE, Hengesch X, Schächinger H. The time course of pupil dilation evoked by visual sexual stimuli: Exploring the underlying ANS mechanisms. Psychophysiology 2017;54:1444-58. [DOI: 10.1111/psyp.12901] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
118 Severs L, Vlemincx E, Ramirez J. The psychophysiology of the sigh: I: The sigh from the physiological perspective. Biological Psychology 2022. [DOI: 10.1016/j.biopsycho.2022.108313] [Reference Citation Analysis]
119 Gatfield J, Brisbare-Roch C, Jenck F, Boss C. Orexin receptor antagonists: a new concept in CNS disorders? ChemMedChem 2010;5:1197-214. [PMID: 20544785 DOI: 10.1002/cmdc.201000132] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
120 Dun NJ, Le Dun, S, Chen C, Hwang LL, Kwok EH, Chang J. Orexins: a role in medullary sympathetic outflow. Regulatory Peptides 2000;96:65-70. [DOI: 10.1016/s0167-0115(00)00202-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
121 Urstadt KR, Coop SH, Banuelos BD, Stanley BG. Behaviorally specific versus non-specific suppression of accumbens shell-mediated feeding by ipsilateral versus bilateral inhibition of the lateral hypothalamus. Behav Brain Res 2013;257:230-41. [PMID: 24100119 DOI: 10.1016/j.bbr.2013.09.048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
122 López M, Nogueiras R, Tena-Sempere M, Diéguez C. Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis. Acta Physiol (Oxf) 2010;198:325-34. [PMID: 19769635 DOI: 10.1111/j.1748-1716.2009.02042.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
123 Smart D, Haynes AC, Williams G, Arch JR. Orexins and the treatment of obesity. Eur J Pharmacol 2002;440:199-212. [PMID: 12007536 DOI: 10.1016/s0014-2999(02)01429-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
124 Thompson MD, Xhaard H, Sakurai T, Rainero I, Kukkonen JP. OX1 and OX2 orexin/hypocretin receptor pharmacogenetics. Front Neurosci 2014;8:57. [PMID: 24834023 DOI: 10.3389/fnins.2014.00057] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
125 Lok R, Smolders KCHJ, Beersma DGM, de Kort YAW. Light, Alertness, and Alerting Effects of White Light: A Literature Overview. J Biol Rhythms 2018;33:589-601. [PMID: 30191746 DOI: 10.1177/0748730418796443] [Cited by in Crossref: 43] [Cited by in F6Publishing: 16] [Article Influence: 10.8] [Reference Citation Analysis]
126 Nishino S, Yoshida Y. History and perspectives of hypocretin/orexin research in sleep medicine. Sleep and Biological Rhythms 2003;1:43-54. [DOI: 10.1046/j.1446-9235.2003.00001.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
127 Angelopoulos N, Goula A, Tolis G. Current knowledge in the neurophysiologic modulation of obesity. Metabolism 2005;54:1202-17. [DOI: 10.1016/j.metabol.2005.04.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
128 Govindaiah G, Cox CL. Modulation of thalamic neuron excitability by orexins. Neuropharmacology 2006;51:414-25. [PMID: 16713607 DOI: 10.1016/j.neuropharm.2006.03.030] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
129 Chang X, Suo L, Xu N, Zhao Y. Orexin-A Stimulates Insulin Secretion Through the Activation of the OX1 Receptor and Mammalian Target of Rapamycin in Rat Insulinoma Cells. Pancreas 2019;48:568-73. [PMID: 30946236 DOI: 10.1097/MPA.0000000000001280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
130 Huang H, Acuna-Goycolea C, Li Y, Cheng HM, Obrietan K, van den Pol AN. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal. J Neurosci 2007;27:4870-81. [PMID: 17475795 DOI: 10.1523/JNEUROSCI.0732-07.2007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
131 Strother LC, Srikiatkhachorn A, Supronsinchai W. Targeted Orexin and Hypothalamic Neuropeptides for Migraine. Neurotherapeutics 2018;15:377-90. [PMID: 29442286 DOI: 10.1007/s13311-017-0602-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
132 Wojciechowicz T, Skrzypski M, Szczepankiewicz D, Hertig I, Kołodziejski PA, Billert M, Strowski MZ, Nowak KW. Original Research: Orexins A and B stimulate proliferation and differentiation of porcine preadipocytes. Exp Biol Med (Maywood) 2016;241:1786-95. [PMID: 27190275 DOI: 10.1177/1535370216649261] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
133 Torterolo P, Ramos OV, Sampogna S, Chase MH. Hypocretinergic neurons are activated in conjunction with goal-oriented survival-related motor behaviors. Physiol Behav 2011;104:823-30. [PMID: 21839102 DOI: 10.1016/j.physbeh.2011.07.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
134 Huang ZL, Qu WM, Li WD, Mochizuki T, Eguchi N, Watanabe T, Urade Y, Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A 2001;98:9965-70. [PMID: 11493714 DOI: 10.1073/pnas.181330998] [Cited by in Crossref: 376] [Cited by in F6Publishing: 336] [Article Influence: 17.9] [Reference Citation Analysis]
135 Lyons DJ, Hellysaz A, Ammari R, Broberger C. Hypocretin/Orexin Peptides Excite Rat Neuroendocrine Dopamine Neurons through Orexin 2 Receptor-Mediated Activation of a Mixed Cation Current. Sci Rep 2017;7:41535. [PMID: 28145492 DOI: 10.1038/srep41535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
136 Hillebrand J, de Wied D, Adan R. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 2002;23:2283-306. [DOI: 10.1016/s0196-9781(02)00269-3] [Cited by in Crossref: 202] [Cited by in F6Publishing: 49] [Article Influence: 10.1] [Reference Citation Analysis]
137 Soffin EM, Gill CH, Brough SJ, Jerman JC, Davies CH. Pharmacological characterisation of the orexin receptor subtype mediating postsynaptic excitation in the rat dorsal raphe nucleus. Neuropharmacology. 2004;46:1168-1176. [PMID: 15111023 DOI: 10.1016/j.neuropharm.2004.02.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
138 Hou RH, Langley RW, Szabadi E, Bradshaw CM. Comparison of diphenhydramine and modafinil on arousal and autonomic functions in healthy volunteers. J Psychopharmacol 2007;21:567-78. [PMID: 17092978 DOI: 10.1177/0269881106071022] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
139 Goforth PB, Myers MG. Roles for Orexin/Hypocretin in the Control of Energy Balance and Metabolism. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 137-56. [DOI: 10.1007/7854_2016_51] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
140 Sakurai T, Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol Sci 2011;32:451-62. [PMID: 21565412 DOI: 10.1016/j.tips.2011.03.007] [Cited by in Crossref: 139] [Cited by in F6Publishing: 136] [Article Influence: 12.6] [Reference Citation Analysis]
141 Tsuneki H, Sugihara Y, Honda R, Wada T, Sasaoka T, Kimura I. Reduction of blood glucose level by orexins in fasting normal and streptozotocin-diabetic mice. European Journal of Pharmacology 2002;448:245-52. [DOI: 10.1016/s0014-2999(02)01936-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
142 Campbell EJ, Norman A, Bonomo Y, Lawrence AJ. Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial. Brain Res 2020;1728:146597. [PMID: 31837287 DOI: 10.1016/j.brainres.2019.146597] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
143 Prober DA. Discovery of Hypocretin/Orexin Ushers in a New Era of Sleep Research. Trends Neurosci 2018;41:70-2. [PMID: 29405929 DOI: 10.1016/j.tins.2017.11.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
144 Zhang J, Li B, Yu L, He YC, Li HZ, Zhu JN, Wang JJ. A role for orexin in central vestibular motor control. Neuron 2011;69:793-804. [PMID: 21338887 DOI: 10.1016/j.neuron.2011.01.026] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
145 Morein-Zamir S, Turner DC, Sahakian BJ. A review of the effects of modafinil on cognition in schizophrenia. Schizophr Bull 2007;33:1298-306. [PMID: 17634412 DOI: 10.1093/schbul/sbm090] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
146 Koyama Y, Takahashi K, Kodama T, Kayama Y. State-dependent activity of neurons in the perifornical hypothalamic area during sleep and waking. Neuroscience 2003;119:1209-19. [DOI: 10.1016/s0306-4522(03)00173-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
147 Bjorness TE, Greene RW. Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking. Pharmacol Biochem Behav 2021;206:173194. [PMID: 33940055 DOI: 10.1016/j.pbb.2021.173194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
148 Hening WA, Allen RP, Walters AS, Chokroverty S. Motor Functions and Dysfunctions of Sleep. Sleep Disorders Medicine. Elsevier; 2009. pp. 397-435. [DOI: 10.1016/b978-0-7506-7584-0.00028-8] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
149 Goadsby PJ, Dodick DW, Almas M, Diener HC, Tfelt-Hansen P, Lipton RB, Parsons B. Treatment-emergent CNS symptoms following triptan therapy are part of the attack. Cephalalgia 2007;27:254-62. [PMID: 17381558 DOI: 10.1111/j.1468-2982.2007.01278.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
150 Rachalski A, Alexandre C, Bernard JF, Saurini F, Lesch KP, Hamon M, Adrien J, Fabre V. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins. J Neurosci 2009;29:15575-85. [PMID: 20007481 DOI: 10.1523/JNEUROSCI.3138-09.2009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
151 Kane JK, Tanaka H, Parker SL, Yanagisawa M, Li MD. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin. Biochem Biophys Res Commun 2000;272:959-65. [PMID: 10860858 DOI: 10.1006/bbrc.2000.2880] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
152 Baldo BA, Daniel RA, Berridge CW, Kelley AE. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 2003;464:220-37. [PMID: 12898614 DOI: 10.1002/cne.10783] [Cited by in Crossref: 247] [Cited by in F6Publishing: 253] [Article Influence: 13.0] [Reference Citation Analysis]
153 Graebner AK, Iyer M, Carter ME. Understanding how discrete populations of hypothalamic neurons orchestrate complicated behavioral states. Front Syst Neurosci 2015;9:111. [PMID: 26300745 DOI: 10.3389/fnsys.2015.00111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
154 Lindberg J, Saetre P, Nishino S, Mignot E, Jazin E. Reduced expression of TAC1, PENK and SOCS2 in Hcrtr-2 mutated narcoleptic dog brain. BMC Neurosci 2007;8:34. [PMID: 17521418 DOI: 10.1186/1471-2202-8-34] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
155 Bai YJ, Li YH, Zheng XG, Han J, Yang XY, Sui N. Orexin A attenuates unconditioned sexual motivation in male rats. Pharmacol Biochem Behav 2009;91:581-9. [PMID: 18952120 DOI: 10.1016/j.pbb.2008.09.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
156 Brischoux F, Mainville L, Jones BE. Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake state control. J Comp Neurol 2008;510:607-30. [DOI: 10.1002/cne.21803] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 2.8] [Reference Citation Analysis]
157 Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009;61:162-76. [PMID: 19549926 DOI: 10.1124/pr.109.001321] [Cited by in Crossref: 314] [Cited by in F6Publishing: 284] [Article Influence: 26.2] [Reference Citation Analysis]
158 Suzuki H, Yamamoto T. Orexin-B-like immunoreactivity localizes in both luteinizing-hormone-containing cells and melanin-concentrating hormone-containing fibers in the red-bellied piranha (Pygocentrus nattereri) pituitary. Cell Tissue Res 2013;351:175-82. [PMID: 23161098 DOI: 10.1007/s00441-012-1516-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
159 Waleh N, Apte-deshpande A, Terao A, Ding J, Kilduff T. Modulation of the promoter region of prepro-hypocretin by α-interferon. Gene 2001;262:123-8. [DOI: 10.1016/s0378-1119(00)00544-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
160 Thorpe AJ, Cleary JP, Levine AS, Kotz CM. Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacology (Berl) 2005;182:75-83. [PMID: 16075284 DOI: 10.1007/s00213-005-0040-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
161 Holland PR. Biology of Neuropeptides: Orexinergic Involvement in Primary Headache Disorders. Headache 2017;57 Suppl 2:76-88. [PMID: 28485849 DOI: 10.1111/head.13078] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
162 Satoh S, Matsumura H, Kanbayashi T, Yoshida Y, Urakami T, Nakajima T, Kimura N, Nishino S, Yoneda H. Expression pattern of FOS in orexin neurons during sleep induced by an adenosine A2A receptor agonist. Behavioural Brain Research 2006;170:277-86. [DOI: 10.1016/j.bbr.2006.03.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
163 Haq IZ, Naidu Y, Reddy P, Chaudhuri KR. Narcolepsy in Parkinson's disease. Expert Rev Neurother 2010;10:879-84. [PMID: 20518604 DOI: 10.1586/ern.10.56] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
164 Ishibashi H, Nakahata Y, Eto K, Nabekura J. Excitation of locus coeruleus noradrenergic neurons by thyrotropin-releasing hormone. J Physiol 2009;587:5709-22. [PMID: 19840999 DOI: 10.1113/jphysiol.2009.181420] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
165 Mieda M, Hasegawa E, Kisanuki YY, Sinton CM, Yanagisawa M, Sakurai T. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 2011;31:6518-26. [PMID: 21525292 DOI: 10.1523/JNEUROSCI.6506-10.2011] [Cited by in Crossref: 134] [Cited by in F6Publishing: 78] [Article Influence: 12.2] [Reference Citation Analysis]
166 de Lecea L, Sutcliffe JG, Fabre V. Hypocretins/orexins as integrators of physiological information: lessons from mutant animals. Neuropeptides 2002;36:85-95. [PMID: 12359500 DOI: 10.1054/npep.2002.0892] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
167 Johnson PL, Molosh A, Fitz SD, Truitt WA, Shekhar A. Orexin, stress, and anxiety/panic states. Prog Brain Res 2012;198:133-61. [PMID: 22813973 DOI: 10.1016/B978-0-444-59489-1.00009-4] [Cited by in Crossref: 125] [Cited by in F6Publishing: 69] [Article Influence: 12.5] [Reference Citation Analysis]
168 Bayer L, Serafin M, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M. Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons. J Neurosci 2004;24:6760-4. [PMID: 15282280 DOI: 10.1523/JNEUROSCI.1783-04.2004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 46] [Article Influence: 6.5] [Reference Citation Analysis]
169 Tafti M, Franken P. Invited Review: Genetic dissection of sleep. Journal of Applied Physiology 2002;92:1339-47. [DOI: 10.1152/japplphysiol.00834.2001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
170 Coborn JE, Lessie RE, Sinton CM, Rance NE, Perez-Leighton CE, Teske JA. Noise-induced sleep disruption increases weight gain and decreases energy metabolism in female rats. Int J Obes (Lond) 2019;43:1759-68. [PMID: 30568267 DOI: 10.1038/s41366-018-0293-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
171 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
172 Cole AG, Stroke IL, Qin L, Hussain Z, Simhadri S, Brescia M, Waksmunski FS, Strohl B, Tellew JE, Williams JP, Saunders J, Appell KC, Henderson I, Webb ML. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2008;18:5420-3. [DOI: 10.1016/j.bmcl.2008.09.038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
173 Apelbaum A, Perrut A, Chaput M. Orexin A effects on the olfactory bulb spontaneous activity and odor responsiveness in freely breathing rats. Regulatory Peptides 2005;129:49-61. [DOI: 10.1016/j.regpep.2005.01.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
174 Datta S, Maclean RR. Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence. Neurosci Biobehav Rev 2007;31:775-824. [PMID: 17445891 DOI: 10.1016/j.neubiorev.2007.02.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 166] [Article Influence: 12.9] [Reference Citation Analysis]
175 Vittoz NM, Berridge CW. Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area. Neuropsychopharmacology 2006;31:384-95. [PMID: 15988471 DOI: 10.1038/sj.npp.1300807] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 7.7] [Reference Citation Analysis]
176 Li Y, van den Pol AN. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides. J Neurosci 2006;26:13037-47. [PMID: 17167093 DOI: 10.1523/JNEUROSCI.3380-06.2006] [Cited by in Crossref: 86] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
177 Kummer M, Neidert SJ, Jöhren O, Dominiak P. Orexin (hypocretin) gene expression in rat ependymal cells: . Neuroreport 2001;12:2117-20. [DOI: 10.1097/00001756-200107200-00015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
178 Lavezzi AM, Ferrero S, Roncati L, Matturri L, Pusiol T. Impaired orexin receptor expression in the Kölliker-Fuse nucleus in sudden infant death syndrome: possible involvement of this nucleus in arousal pathophysiology. Neurol Res 2016;38:706-16. [PMID: 27353953 DOI: 10.1080/01616412.2016.1201632] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
179 Matsuki T, Sakurai T. Orexins and Orexin Receptors: From Molecules to Integrative Physiology. In: Civelli O, Zhou Q, editors. Orphan G Protein-Coupled Receptors and Novel Neuropeptides. Berlin: Springer Berlin Heidelberg; 2008. pp. 27-55. [DOI: 10.1007/400_2007_047] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Reference Citation Analysis]
180 Hurley SW, Johnson AK. The role of the lateral hypothalamus and orexin in ingestive behavior: a model for the translation of past experience and sensed deficits into motivated behaviors. Front Syst Neurosci 2014;8:216. [PMID: 25431553 DOI: 10.3389/fnsys.2014.00216] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
181 Luppi P, Clément O, Sapin E, Gervasoni D, Peyron C, Léger L, Salvert D, Fort P. The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorder. Sleep Medicine Reviews 2011;15:153-63. [DOI: 10.1016/j.smrv.2010.08.002] [Cited by in Crossref: 176] [Cited by in F6Publishing: 146] [Article Influence: 16.0] [Reference Citation Analysis]
182 Henry BA, Rao A, Ikenasio BA, Mountjoy KG, Tilbrook AJ, Clarke IJ. Differential expression of cocaine- and amphetamine-regulated transcript and agouti related-protein in chronically food-restricted sheep. Brain Research 2001;918:40-50. [DOI: 10.1016/s0006-8993(01)02918-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
183 Suzuki H, Takemoto Y, Yamamoto T. Differential distribution of orexin-A-like and orexin receptor 1 (OX1R)-like immunoreactivities in the Xenopus pituitary. Tissue Cell 2007;39:423-30. [PMID: 17897692 DOI: 10.1016/j.tice.2007.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
184 Kaushik MK, Aritake K, Imanishi A, Kanbayashi T, Ichikawa T, Shimizu T, Urade Y, Yanagisawa M. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Proc Natl Acad Sci U S A 2018;115:6046-51. [PMID: 29784823 DOI: 10.1073/pnas.1722686115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
185 Samson WK, Taylor MM, Follwell M, Ferguson AV. Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 2002;104:97-103. [PMID: 11830283 DOI: 10.1016/s0167-0115(01)00353-6] [Cited by in Crossref: 92] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
186 Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Massi M, Ciccocioppo R. Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 2009;34:2125-34. [PMID: 19322167 DOI: 10.1038/npp.2009.37] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 5.4] [Reference Citation Analysis]
187 Telegdy G, Adamik A. The action of orexin A on passive avoidance learning. Involvement of transmitters. Regul Pept 2002;104:105-10. [PMID: 11830284 DOI: 10.1016/s0167-0115(01)00341-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
188 Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S, Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7. [PMID: 10973318 DOI: 10.1038/79690] [Cited by in Crossref: 1341] [Cited by in F6Publishing: 1194] [Article Influence: 61.0] [Reference Citation Analysis]
189 Stanley S, Wynne K, McGowan B, Bloom S. Hormonal regulation of food intake. Physiol Rev. 2005;85:1131-1158. [PMID: 16183909 DOI: 10.1152/physrev.00015.2004] [Cited by in Crossref: 240] [Cited by in F6Publishing: 215] [Article Influence: 14.1] [Reference Citation Analysis]
190 Korotkova TM, Eriksson KS, Haas HL, Brown RE. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 2002;104:83-9. [PMID: 11830281 DOI: 10.1016/s0167-0115(01)00323-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
191 Summers CH, Yaeger JDW, Staton CD, Arendt DH, Summers TR. Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy. Brain Res 2020;1731:146085. [PMID: 30590027 DOI: 10.1016/j.brainres.2018.12.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
192 Goadsby P, Charbit A, Andreou A, Akerman S, Holland P. Neurobiology of migraine. Neuroscience 2009;161:327-41. [DOI: 10.1016/j.neuroscience.2009.03.019] [Cited by in Crossref: 260] [Cited by in F6Publishing: 230] [Article Influence: 20.0] [Reference Citation Analysis]
193 Cote-Vélez A, Martínez Báez A, Lezama L, Uribe RM, Joseph-Bravo P, Charli JL. A screen for modulators reveals that orexin-A rapidly stimulates thyrotropin releasing hormone expression and release in hypothalamic cell culture. Neuropeptides 2017;62:11-20. [PMID: 28173961 DOI: 10.1016/j.npep.2017.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
194 Perez SM, Lodge DJ. Orexin Modulation of VTA Dopamine Neuron Activity: Relevance to Schizophrenia. Int J Neuropsychopharmacol 2021;24:344-53. [PMID: 33587746 DOI: 10.1093/ijnp/pyaa080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Pearson KA, Stephen A, Beck SG, Valentino RJ. Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar-Kyoto rats. Neuropsychopharmacology 2006;31:2449-61. [PMID: 16710313 DOI: 10.1038/sj.npp.1301100] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
196 Silva JP, von Meyenn F, Howell J, Thorens B, Wolfrum C, Stoffel M. Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 2009;462:646-50. [PMID: 19956259 DOI: 10.1038/nature08589] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 4.1] [Reference Citation Analysis]
197 Darwinkel A, Stanić D, Booth LC, May CN, Lawrence AJ, Yao ST. Distribution of orexin-1 receptor-green fluorescent protein- (OX1-GFP) expressing neurons in the mouse brain stem and pons: Co-localization with tyrosine hydroxylase and neuronal nitric oxide synthase. Neuroscience 2014;278:253-64. [PMID: 25168728 DOI: 10.1016/j.neuroscience.2014.08.027] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
198 John J, Wu MF, Kodama T, Siegel JM. Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats. J Physiol 2003;548:557-62. [PMID: 12626669 DOI: 10.1113/jphysiol.2002.038729] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
199 Luppi AI, Spindler LRB, Menon DK, Stamatakis EA. The Inert Brain: Explaining Neural Inertia as Post-anaesthetic Sleep Inertia. Front Neurosci 2021;15:643871. [PMID: 33737863 DOI: 10.3389/fnins.2021.643871] [Reference Citation Analysis]
200 Zeitzer JM, Buckmaster CL, Lyons DM, Mignot E. Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J Physiol 2004;557:1045-53. [PMID: 15107479 DOI: 10.1113/jphysiol.2004.061606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
201 Prober DA, Rihel J, Onah AA, Sung RJ, Schier AF. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 2006;26:13400-10. [PMID: 17182791 DOI: 10.1523/JNEUROSCI.4332-06.2006] [Cited by in Crossref: 308] [Cited by in F6Publishing: 153] [Article Influence: 20.5] [Reference Citation Analysis]
202 Muehlan C, Vaillant C, Zenklusen I, Kraehenbuehl S, Dingemanse J. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders. Expert Opinion on Drug Metabolism & Toxicology 2020;16:1063-78. [DOI: 10.1080/17425255.2020.1817380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
203 Novikova NS, Perekrest SV, Shainidze KZ, Korneva EA. Hypothalamic Orexin-Containing Neurons in the Hypothalamus on Exposure to Antigenic and Non-Antigenic Stimuli. Neurosci Behav Physi 2011;41:188-97. [DOI: 10.1007/s11055-011-9399-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
204 Nixon J, Smale L. Individual differences in wheel-running rhythms are related to temporal and spatial patterns of activation of orexin A and B cells in a diurnal rodent (arvicanthis niloticus). Neuroscience 2004;127:25-34. [DOI: 10.1016/j.neuroscience.2004.04.052] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
205 Kim SW, Lee BI. Metabolic state, neurohormones, and vagal stimulation, not increased serotonin, orchestrate postprandial drowsiness. Bioscience Hypotheses 2009;2:422-7. [DOI: 10.1016/j.bihy.2009.07.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
206 Peterfi Z, Obal F, Taishi P, Gardi J, Kacsoh B, Unterman T, Krueger JM. Sleep in spontaneous dwarf rats. Brain Research 2006;1108:133-46. [DOI: 10.1016/j.brainres.2006.06.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
207 Héricé C, Patel AA, Sakata S. Circuit mechanisms and computational models of REM sleep. Neurosci Res 2019;140:77-92. [PMID: 30118737 DOI: 10.1016/j.neures.2018.08.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
208 Kordi Jaz E, Moghimi A, Fereidoni M, Asadi S, Shamsizadeh A, Roohbakhsh A. SB-334867, an orexin receptor 1 antagonist, decreased seizure and anxiety in pentylenetetrazol-kindled rats. Fundam Clin Pharmacol 2017;31:201-7. [DOI: 10.1111/fcp.12249] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
209 Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ. Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology 2012;37:1224-33. [PMID: 22237311 DOI: 10.1038/npp.2011.310] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
210 Betschart C, Hintermann S, Behnke D, Cotesta S, Fendt M, Gee CE, Jacobson LH, Laue G, Ofner S, Chaudhari V, Badiger S, Pandit C, Wagner J, Hoyer D. Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomnia. J Med Chem 2013;56:7590-607. [PMID: 23964859 DOI: 10.1021/jm4007627] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
211 De la Herrán-Arita AK, Guerra-Crespo M, Drucker-Colín R. Narcolepsy and orexins: an example of progress in sleep research. Front Neurol 2011;2:26. [PMID: 21541306 DOI: 10.3389/fneur.2011.00026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
212 Messina A, De Fusco C, Monda V, Esposito M, Moscatelli F, Valenzano A, Carotenuto M, Viggiano E, Chieffi S, De Luca V, Cibelli G, Monda M, Messina G. Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis. Front Neural Circuits 2016;10:66. [PMID: 27610076 DOI: 10.3389/fncir.2016.00066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
213 Meerabux J, Iwayama Y, Sakurai T, Ohba H, Toyota T, Yamada K, Nagata R, Irukayama-tomobe Y, Shimizu H, Yoshitsugu K, Ohta K, Yoshikawa T. Association of An Orexin 1 Receptor 408Val Variant with Polydipsia–Hyponatremia in Schizophrenic Subjects. Biological Psychiatry 2005;58:401-7. [DOI: 10.1016/j.biopsych.2005.04.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
214 Mistlberger RE. Circadian regulation of sleep in mammals: Role of the suprachiasmatic nucleus. Brain Research Reviews 2005;49:429-54. [DOI: 10.1016/j.brainresrev.2005.01.005] [Cited by in Crossref: 204] [Cited by in F6Publishing: 173] [Article Influence: 12.0] [Reference Citation Analysis]
215 Bahammam AS, Almushailhi K, Pandi-Perumal SR, Sharif MM. Intermittent fasting during Ramadan: does it affect sleep? J Sleep Res 2014;23:35-43. [PMID: 23937329 DOI: 10.1111/jsr.12076] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
216 Haxhiu MA, Rust CF, Brooks C, Kc P. CNS determinants of sleep-related worsening of airway functions: implications for nocturnal asthma. Respir Physiol Neurobiol 2006;151:1-30. [PMID: 16198640 DOI: 10.1016/j.resp.2005.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
217 Luppi PH, Gervasoni D, Verret L, Goutagny R, Peyron C, Salvert D, Leger L, Fort P. Paradoxical (REM) sleep genesis: the switch from an aminergic-cholinergic to a GABAergic-glutamatergic hypothesis. J Physiol Paris 2006;100:271-83. [PMID: 17689057 DOI: 10.1016/j.jphysparis.2007.05.006] [Cited by in Crossref: 121] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
218 Thorpe AJ, Mullett MA, Wang C, Kotz CM. Regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2003;284:R1409-17. [DOI: 10.1152/ajpregu.00344.2002] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 3.1] [Reference Citation Analysis]
219 Boutrel B. A neuropeptide-centric view of psychostimulant addiction. Br J Pharmacol 2008;154:343-57. [PMID: 18414383 DOI: 10.1038/bjp.2008.133] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
220 Ford GK, Al-barazanji KA, Wilson S, Jones DNC, Harbuz MS, Jessop DS. Orexin Expression and Function: Glucocorticoid Manipulation, Stress, and Feeding Studies. Endocrinology 2005;146:3724-31. [DOI: 10.1210/en.2005-0496] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
221 Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-Orexin and Orexin Receptor mRNAs Are Differentially Expressed in Peripheral Tissues of Male and Female Rats. Endocrinology 2001;142:3324-31. [DOI: 10.1210/endo.142.8.8299] [Cited by in Crossref: 133] [Cited by in F6Publishing: 144] [Article Influence: 6.3] [Reference Citation Analysis]
222 Jöhren O, Neidert SJ, Kummer M, Dominiak P. Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides 2002;23:1177-80. [DOI: 10.1016/s0196-9781(02)00052-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
223 Pedrazzoli M, D'almeida V, Martins PJ, Machado RB, Ling L, Nishino S, Tufik S, Mignot E. Increased hypocretin-1 levels in cerebrospinal fluid after REM sleep deprivation. Brain Research 2004;995:1-6. [DOI: 10.1016/j.brainres.2003.09.032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
224 Tanaka S. Transcriptional regulation of the hypocretin/orexin gene. Vitam Horm 2012;89:75-90. [PMID: 22640609 DOI: 10.1016/B978-0-12-394623-2.00005-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
225 Sakurai T. Roles of orexins in regulation of feeding and wakefulness: . Neuroreport 2002;13:987-95. [DOI: 10.1097/00001756-200206120-00001] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 3.9] [Reference Citation Analysis]
226 Nicolaidis S. Metabolic mechanism of wakefulness (and hunger) and sleep (and satiety): Role of adenosine triphosphate and hypocretin and other peptides. Metabolism 2006;55:S24-9. [PMID: 16979423 DOI: 10.1016/j.metabol.2006.07.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
227 Kane JK, Parker SL, Matta SG, Fu Y, Sharp BM, Li MD. Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology 2000;141:3623-9. [PMID: 11014216 DOI: 10.1210/endo.141.10.7707] [Cited by in Crossref: 49] [Cited by in F6Publishing: 63] [Article Influence: 2.2] [Reference Citation Analysis]
228 Mieda M, Sakurai T. Overview of orexin/hypocretin system. Orexin/Hypocretin System. Elsevier; 2012. pp. 5-14. [DOI: 10.1016/b978-0-444-59489-1.00002-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
229 Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain 2004;109:367-78. [DOI: 10.1016/j.pain.2004.02.005] [Cited by in Crossref: 204] [Cited by in F6Publishing: 162] [Article Influence: 11.3] [Reference Citation Analysis]
230 Nixon JP, Smale L. A comparative analysis of the distribution of immunoreactive orexin A and B in the brains of nocturnal and diurnal rodents. Behav Brain Funct 2007;3:28. [PMID: 17567902 DOI: 10.1186/1744-9081-3-28] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 5.9] [Reference Citation Analysis]
231 Van Den Pol AN, Patrylo PR, Ghosh PK, Gao X. Lateral hypothalamus: Early developmental expression and response to hypocretin (orexin). J Comp Neurol 2001;433:349-63. [DOI: 10.1002/cne.1144] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 3.1] [Reference Citation Analysis]
232 He Y, Kudo M, Kudo T, Kushikata T, Li E, Hirota K. The Effects of Benzodiazepines on Orexinergic Systems in Rat Cerebrocortical Slices: . Anesthesia & Analgesia 2007;104:338-40. [DOI: 10.1213/01.ane.0000252413.62821.2e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
233 Yamanaka A, Beuckmann CT, Willie JT, Hara J, Tsujino N, Mieda M, Tominaga M, Yagami Ki, Sugiyama F, Goto K, Yanagisawa M, Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003;38:701-13. [PMID: 12797956 DOI: 10.1016/s0896-6273(03)00331-3] [Cited by in Crossref: 595] [Cited by in F6Publishing: 310] [Article Influence: 31.3] [Reference Citation Analysis]
234 Simpson KA, Bloom SR. Appetite and Hedonism: Gut Hormones and the Brain. Endocrinology and Metabolism Clinics of North America 2010;39:729-43. [DOI: 10.1016/j.ecl.2010.08.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
235 Samuels ER, Szabadi E. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 2008;6:235-53. [PMID: 19506723 DOI: 10.2174/157015908785777229] [Cited by in Crossref: 389] [Cited by in F6Publishing: 362] [Article Influence: 32.4] [Reference Citation Analysis]
236 Zhang T, Wang M, Pan L, Ding W, Wang J, Yang L, Liu M, Li W, Yan Z. Study of Gene Expression Profiles and Biological Mechanism of Cerebral Palsy Using a Monozygotic Twin Pair. Twin Res Hum Genet 2007;10:496-507. [DOI: 10.1375/twin.10.3.496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
237 Takahashi K, Arihara Z, Suzuki T, Sone M, Kikuchi K, Sasano H, Murakami O, Totsune K. Expression of orexin-A and orexin receptors in the kidney and the presence of orexin-A-like immunoreactivity in human urine. Peptides 2006;27:871-7. [PMID: 16202475 DOI: 10.1016/j.peptides.2005.08.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
238 Fronczek R, Baumann CR, Lammers GJ, Bassetti CL, Overeem S. Hypocretin/orexin disturbances in neurological disorders. Sleep Medicine Reviews 2009;13:9-22. [DOI: 10.1016/j.smrv.2008.05.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
239 Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001;30:345-54. [PMID: 11394998 DOI: 10.1016/s0896-6273(01)00293-8] [Cited by in Crossref: 945] [Cited by in F6Publishing: 403] [Article Influence: 45.0] [Reference Citation Analysis]
240 Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu MF, John J, Peever J, Siegel JM. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002;22:5282-6. [PMID: 12097478 DOI: 20026541] [Cited by in Crossref: 224] [Article Influence: 11.2] [Reference Citation Analysis]
241 Székely M, Pétervári E, Balaskó M, Hernádi I, Uzsoki B. Effects of orexins on energy balance and thermoregulation. Regul Pept 2002;104:47-53. [PMID: 11830276 DOI: 10.1016/s0167-0115(01)00348-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
242 Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T, Yanagisawa M. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004;24:4469-77. [PMID: 15128861 DOI: 10.1523/JNEUROSCI.5560-03.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 57] [Article Influence: 7.1] [Reference Citation Analysis]
243 Puskás N, Papp RS, Gallatz K, Palkovits M. Interactions between orexin-immunoreactive fibers and adrenaline or noradrenaline-expressing neurons of the lower brainstem in rats and mice. Peptides 2010;31:1589-97. [PMID: 20434498 DOI: 10.1016/j.peptides.2010.04.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
244 Vasquez JH, Borniger JC. Neuroendocrine and Behavioral Consequences of Hyperglycemia in Cancer. Endocrinology 2020;161:bqaa047. [PMID: 32193527 DOI: 10.1210/endocr/bqaa047] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
245 van der Ark PD, Golor G, van Nueten L, Nandy P, de Boer P. Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects. J Psychopharmacol 2018;32:1330-40. [DOI: 10.1177/0269881118791521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
246 España RA, Melchior JR, Roberts DC, Jones SR. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration. Psychopharmacology (Berl) 2011;214:415-26. [PMID: 20959967 DOI: 10.1007/s00213-010-2048-8] [Cited by in Crossref: 109] [Cited by in F6Publishing: 109] [Article Influence: 9.1] [Reference Citation Analysis]
247 Li S, Franken P, Vassalli A. Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin/Orexin receptor 1-KO mice. Sci Rep 2018;8:15474. [PMID: 30341359 DOI: 10.1038/s41598-018-33069-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
248 Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motoneurons. J Neurosci 2004;24:5336-45. [PMID: 15190106 DOI: 10.1523/JNEUROSCI.4812-03.2004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
249 Nevárez N, de Lecea L. Hypocretin and the Regulation of Sleep-Wake Transitions. Handbook of Sleep Research. Elsevier; 2019. pp. 89-99. [DOI: 10.1016/b978-0-12-813743-7.00006-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
250 Wafford KA, Ebert B. Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time. Nat Rev Drug Discov 2008;7:530-40. [PMID: 18511929 DOI: 10.1038/nrd2464] [Cited by in Crossref: 71] [Cited by in F6Publishing: 58] [Article Influence: 5.1] [Reference Citation Analysis]
251 Chudasama Y, Robbins TW. Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia. Psychopharmacology (Berl) 2004;174:86-98. [PMID: 15071717 DOI: 10.1007/s00213-004-1805-y] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 5.0] [Reference Citation Analysis]
252 Katayama S, Shigemi K, Cline MA, Furuse M. Intracerebroventricular injection of orexin-A stimulates monoamine metabolism but not HPA axis in neonatal chicks. Neuroscience Letters 2010;484:157-61. [DOI: 10.1016/j.neulet.2010.08.043] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
253 Simmons SJ, Gentile TA. Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect. Brain Res 2020;1731:146164. [PMID: 30796894 DOI: 10.1016/j.brainres.2019.02.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
254 Tsujino N, Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci 2013;7:28. [PMID: 23616752 DOI: 10.3389/fnbeh.2013.00028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 15.0] [Reference Citation Analysis]
255 Liu X, Zeng J, Zhou A, Theodorsson E, Fahrenkrug J, Reinscheid RK. Molecular fingerprint of neuropeptide S-producing neurons in the mouse brain. J Comp Neurol 2011;519:1847-66. [PMID: 21452230 DOI: 10.1002/cne.22603] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
256 Azeez IA, Del Gallo F, Cristino L, Bentivoglio M. Daily Fluctuation of Orexin Neuron Activity and Wiring: The Challenge of "Chronoconnectivity". Front Pharmacol 2018;9:1061. [PMID: 30319410 DOI: 10.3389/fphar.2018.01061] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
257 Pekala D, Blasiak T, Raastad M, Lewandowski MH. The influence of orexins on the firing rate and pattern of rat intergeniculate leaflet neurons - electrophysiological and immunohistological studies: Influence of orexins on intergeniculate leaflet. European Journal of Neuroscience 2011;34:1406-18. [DOI: 10.1111/j.1460-9568.2011.07868.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
258 Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron. 2004;43:487-497. [PMID: 15312648 DOI: 10.1016/j.neuron.2004.08.005] [Cited by in Crossref: 365] [Cited by in F6Publishing: 364] [Article Influence: 20.3] [Reference Citation Analysis]
259 Liguori C, Mercuri NB, Nuccetelli M, Izzi F, Cordella A, Bernardini S, Placidi F. Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? Sleep Medicine 2019;56:171-6. [DOI: 10.1016/j.sleep.2019.01.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
260 Takahashi K, Koyama Y, Kayama Y, Yamamoto M. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin Neurosci 2002;56:335-6. [DOI: 10.1046/j.1440-1819.2002.00967.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 2.7] [Reference Citation Analysis]
261 Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, Scammell TE. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001;21:1656-62. [PMID: 11222656 [PMID: 11222656 DOI: 10.1523/jneurosci.21-05-01656.2001] [Cited by in Crossref: 455] [Article Influence: 21.7] [Reference Citation Analysis]
262 Rodgers RJ, Wright FL, Snow NF, Taylor LJ. Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice. Behav Brain Res 2013;243:213-9. [PMID: 23333844 DOI: 10.1016/j.bbr.2012.12.064] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
263 Jackson KL, Dampney BW, Moretti JL, Stevenson ER, Davern PJ, Carrive P, Head GA. Contribution of Orexin to the Neurogenic Hypertension in BPH/2J Mice. Hypertension 2016;67:959-69. [PMID: 26975709 DOI: 10.1161/HYPERTENSIONAHA.115.07053] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
264 Davoudi M, Vijeepallam K, Azizi H, Mirnajafi-Zadeh J, Semnanian S. PKC inhibitor reversed the suppressive effect of orexin-A on IPSCs of locus coeruleus neurons in naloxone-induced morphine withdrawal. J Neural Transm (Vienna) 2019;126:1425-35. [PMID: 31493096 DOI: 10.1007/s00702-019-02064-2] [Reference Citation Analysis]
265 Sasson R, Dearth RK, White RS, Chappell PE, Mellon PL. Orexin A induces GnRH gene expression and secretion from GT1-7 hypothalamic GnRH neurons. Neuroendocrinology 2006;84:353-63. [PMID: 17192702 DOI: 10.1159/000098333] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
266 Mesaros A, Koralov SB, Rother E, Wunderlich FT, Ernst MB, Barsh GS, Rajewsky K, Brüning JC. Activation of Stat3 signaling in AgRP neurons promotes locomotor activity. Cell Metab 2008;7:236-48. [PMID: 18316029 DOI: 10.1016/j.cmet.2008.01.007] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 6.1] [Reference Citation Analysis]
267 Ikeno T, Yan L. A comparison of the orexin receptor distribution in the brain between diurnal Nile grass rats (Arvicanthis niloticus) and nocturnal mice (Mus musculus). Brain Res 2018;1690:89-95. [PMID: 29630859 DOI: 10.1016/j.brainres.2018.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
268 Sutcliffe JG, de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000;62:161-8. [PMID: 11020209 DOI: 10.1002/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1] [Cited by in Crossref: 149] [Cited by in F6Publishing: 42] [Article Influence: 6.8] [Reference Citation Analysis]
269 Mondal MS, Nakazato M, Matsukura S. Orexins (hypocretins): novel hypothalamic peptides with divergent functions. Biochem Cell Biol 2000;78:299-305. [DOI: 10.1139/o00-022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
270 Liu M, Min T, Zhang H, Liu Y, Wang Z. Pharmacological Characteristics of Porcine Orexin 2 Receptor and Mutants. Front Endocrinol (Lausanne) 2020;11:132. [PMID: 32296386 DOI: 10.3389/fendo.2020.00132] [Reference Citation Analysis]
271 Shaw JK, Ferris MJ, Locke JL, Brodnik ZD, Jones SR, España RA. Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine. Addict Biol 2017;22:1695-705. [PMID: 27480648 DOI: 10.1111/adb.12432] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
272 Ohkubo T, Boswell T, Lumineau S. Molecular cloning of chicken prepro-orexin cDNA and preferential expression in the chicken hypothalamus. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 2002;1577:476-80. [DOI: 10.1016/s0167-4781(02)00483-9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
273 Bayer L, Eggermann E, Saint-Mleux B, Machard D, Jones BE, Mühlethaler M, Serafin M. Selective action of orexin (hypocretin) on nonspecific thalamocortical projection neurons. J Neurosci 2002;22:7835-9. [PMID: 12223534 [PMID: 12223534 DOI: 10.1523/jneurosci.22-18-07835.2002] [Cited by in Crossref: 107] [Article Influence: 5.4] [Reference Citation Analysis]
274 Torrealba F, Yanagisawa M, Saper CB. Colocalization of orexin a and glutamate immunoreactivity in axon terminals in the tuberomammillary nucleus in rats. Neuroscience 2003;119:1033-44. [PMID: 12831862 DOI: 10.1016/s0306-4522(03)00238-0] [Cited by in Crossref: 134] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
275 Leibowitz SF, Wortley KE. Hypothalamic control of energy balance: different peptides, different functions. Peptides 2004;25:473-504. [PMID: 15134868 DOI: 10.1016/j.peptides.2004.02.006] [Cited by in Crossref: 162] [Cited by in F6Publishing: 155] [Article Influence: 9.5] [Reference Citation Analysis]
276 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness: 2012 Update. Sleep Med Clin 2012;7:469-86. [PMID: 23162386 DOI: 10.1016/j.jsmc.2012.06.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
277 Blasiak A, Gundlach AL, Hess G, Lewandowski MH. Interactions of Circadian Rhythmicity, Stress and Orexigenic Neuropeptide Systems: Implications for Food Intake Control. Front Neurosci 2017;11:127. [PMID: 28373831 DOI: 10.3389/fnins.2017.00127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
278 Nishino S. The hypothalamic peptidergic system, hypocretin/orexin and vigilance control. Neuropeptides 2007;41:117-33. [DOI: 10.1016/j.npep.2007.01.003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
279 Mahoney CE, Brewer JM, Bittman EL. Central control of circadian phase in arousal-promoting neurons. PLoS One 2013;8:e67173. [PMID: 23826226 DOI: 10.1371/journal.pone.0067173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
280 Bocian R, Kazmierska P, Kłos-Wojtczak P, Kowalczyk T, Konopacki J. Orexinergic theta rhythm in the rat hippocampal formation: In vitro and in vivo findings. Hippocampus 2015;25:1393-406. [PMID: 25820995 DOI: 10.1002/hipo.22459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
281 Watson CJ, Baghdoyan HA, Lydic R. Neuropharmacology of Sleep and Wakefulness. Sleep Med Clin 2010;5:513-28. [PMID: 21278831 DOI: 10.1016/j.jsmc.2010.08.003] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
282 Eriksson KS, Sergeeva OA, Haas HL, Selbach O. Orexins/hypocretins and aminergic systems. Acta Physiol (Oxf) 2010;198:263-75. [PMID: 19566795 DOI: 10.1111/j.1748-1716.2009.02015.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
283 Fujimoto T, Rikimaru K, Fukuda K, Sugimoto H, Masuda K, Ohyabu N, Banno Y, Tokunaga N, Kawamoto T, Tomata Y, Kumagai Y, Iida M, Nagano Y, Yoneyama-hirozane M, Shimizu Y, Sasa K, Ishikawa T, Yukitake H, Ito M, Aoyama K, Matsumoto T. Discovery of TAK-925 as a Potent, Selective, and Brain-Penetrant Orexin 2 Receptor Agonist. ACS Med Chem Lett . [DOI: 10.1021/acsmedchemlett.1c00626] [Reference Citation Analysis]
284 Aston-jones G. Locus Coeruleus, A5 and A7 Noradrenergic Cell Groups. The Rat Nervous System. Elsevier; 2004. pp. 259-94. [DOI: 10.1016/b978-012547638-6/50012-2] [Cited by in Crossref: 40] [Article Influence: 2.2] [Reference Citation Analysis]
285 Franceschini C, Pizza F, Antelmi E, Folli MC, Plazzi G. Narcolepsy treatment: pharmacological and behavioral strategies in adults and children. Sleep Breath 2020;24:615-27. [PMID: 31290083 DOI: 10.1007/s11325-019-01894-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
286 Muraki Y, Yamanaka A, Tsujino N, Kilduff TS, Goto K, Sakurai T. Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor. J Neurosci 2004;24:7159-66. [PMID: 15306649 DOI: 10.1523/JNEUROSCI.1027-04.2004] [Cited by in Crossref: 127] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
287 Shiba T, Ozu M, Yoshida Y, Mignot E, Nishino S. Hypocretin stimulates [(35)S]GTP gamma S binding in Hcrtr 2-transfected cell lines and in brain homogenate. Biochem Biophys Res Commun 2002;294:615-20. [PMID: 12056812 DOI: 10.1016/S0006-291X(02)00521-1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
288 Brisbare-roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007;13:150-5. [DOI: 10.1038/nm1544] [Cited by in Crossref: 396] [Cited by in F6Publishing: 371] [Article Influence: 26.4] [Reference Citation Analysis]
289 De La Herrán-Arita AK, Zomosa-Signoret VC, Millán-Aldaco DA, Palomero-Rivero M, Guerra-Crespo M, Drucker-Colín R, Vidaltamayo R. Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice. Neuroscience 2011;183:134-43. [PMID: 21435382 DOI: 10.1016/j.neuroscience.2011.03.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
290 Zhang JH, Sampogna S, Morales FR, Chase MH. Age-related changes in hypocretin (orexin) immunoreactivity in the cat brainstem. Brain Res 2002;930:206-11. [PMID: 11879811 DOI: 10.1016/s0006-8993(02)02240-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
291 Karasawa H, Yakabi S, Wang L, Taché Y. Orexin-1 receptor mediates the increased food and water intake induced by intracerebroventricular injection of the stable somatostatin pan-agonist, ODT8-SST in rats. Neurosci Lett 2014;576:88-92. [PMID: 24915296 DOI: 10.1016/j.neulet.2014.05.063] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
292 Gravett N, Bhagwandin A, Fuxe K, Manger PR. Distribution of orexin-A immunoreactive neurons and their terminal networks in the brain of the rock hyrax, Procavia capensis. J Chem Neuroanat 2011;41:86-96. [PMID: 21126575 DOI: 10.1016/j.jchemneu.2010.11.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
293 Overeem S, Kok SW, Lammers GJ, Vein AA, Frölich M, Meinders AE, Roelfsema F, Pijl H. Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events. Am J Physiol Endocrinol Metab 2003;284:E641-7. [PMID: 12453828 DOI: 10.1152/ajpendo.00421.2002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
294 Nishino S, Mignot E. Wake-Promoting Medications: Basic Mechanisms and Pharmacology. Principles and Practice of Sleep Medicine. Elsevier; 2005. pp. 468-83. [DOI: 10.1016/b0-72-160797-7/50045-8] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
295 Hirota K, Kushikata T, Kudo M, Kudo T, Lambert DG, Matsuki A. Orexin A and B evoke noradrenaline release from rat cerebrocortical slices. Br J Pharmacol 2001;134:1461-6. [PMID: 11724752 DOI: 10.1038/sj.bjp.0704409] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
296 Sakurai T, Yanagisawa M, Mieda M. Rodent Models of Human Narcolepsy-cataplexy. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 27-38. [DOI: 10.1007/0-387-25446-3_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
297 Martin G, Fabre V, Siggins GR, de Lecea L. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul Pept 2002;104:111-7. [PMID: 11830285 DOI: 10.1016/s0167-0115(01)00354-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
298 Beuckmann CT, Ueno T, Nakagawa M, Suzuki M, Akasofu S. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation. Sleep 2019;42:zsz076. [PMID: 30923834 DOI: 10.1093/sleep/zsz076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
299 Cannella N, Kallupi M, Ruggeri B, Ciccocioppo R, Ubaldi M. The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission. Prog Neurobiol 2013;100:48-59. [PMID: 23041581 DOI: 10.1016/j.pneurobio.2012.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
300 Takahashi K, Wang QP, Guan JL, Kayama Y, Shioda S, Koyama Y. State-dependent effects of orexins on the serotonergic dorsal raphe neurons in the rat. Regul Pept 2005;126:43-7. [PMID: 15620412 DOI: 10.1016/j.regpep.2004.08.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
301 Kirchgessner AL. Orexins in the brain-gut axis. Endocr Rev. 2002;23:1-15. [PMID: 11844742 DOI: 10.1210/edrv.23.1.0454] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
302 Mehta R, Singh A, Mallick BN. Disciplined sleep for healthy living: Role of noradrenaline. World J Neurol 2017; 7(1): 6-23 [DOI: 10.5316/wjn.v7.i1.6] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
303 Surendran S, Campbell GA, Tyring SK, Matalon K, McDonald JD, Matalon R. High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU. Neurochem Res 2003;28:1891-4. [PMID: 14649732 DOI: 10.1023/a:1026184127689] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
304 Karnani MM, Schöne C, Bracey EF, González JA, Viskaitis P, Li HT, Adamantidis A, Burdakov D. Role of spontaneous and sensory orexin network dynamics in rapid locomotion initiation. Prog Neurobiol 2020;187:101771. [PMID: 32058043 DOI: 10.1016/j.pneurobio.2020.101771] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
305 Ito M. Functional roles of neuropeptides in cerebellar circuits. Neuroscience 2009;162:666-72. [PMID: 19361475 DOI: 10.1016/j.neuroscience.2009.01.019] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
306 Papuć E, Stelmasiak Z, Grieb P, Paweł G, Rejdak K. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients. Neurosci Lett 2010;474:9-12. [PMID: 20193740 DOI: 10.1016/j.neulet.2010.02.062] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
307 Nishino S, Ripley B, Overeem S, Nevsimalova S, Lammers GJ, Vankova J, Okun M, Rogers W, Brooks S, Mignot E. Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol 2001;50:381-8. [PMID: 11558795 DOI: 10.1002/ana.1130] [Cited by in Crossref: 308] [Cited by in F6Publishing: 261] [Article Influence: 14.7] [Reference Citation Analysis]
308 Kotz C, Nixon J, Butterick T, Perez-Leighton C, Teske J, Billington C. Brain orexin promotes obesity resistance. Ann N Y Acad Sci 2012;1264:72-86. [PMID: 22803681 DOI: 10.1111/j.1749-6632.2012.06585.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 5.8] [Reference Citation Analysis]
309 Zhu L, Onaka T, Sakurai T, Yada T. Activation of orexin neurones after noxious but not conditioned fear stimuli in rats. Neuroreport 2002;13:1351-3. [PMID: 12151801 DOI: 10.1097/00001756-200207190-00027] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
310 Mohammed M, Ootsuka Y, Yanagisawa M, Blessing W. Reduced brown adipose tissue thermogenesis during environmental interactions in transgenic rats with ataxin-3-mediated ablation of hypothalamic orexin neurons. Am J Physiol Regul Integr Comp Physiol 2014;307:R978-89. [PMID: 25324552 DOI: 10.1152/ajpregu.00260.2014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
311 Chen X, Chen L, Du Y. Orexin-A increases the firing activity of hippocampal CA1 neurons through orexin-1 receptors: Orexin-A in Hippocampal CA1 Neurons. Journal of Neuroscience Research 2017;95:1415-26. [DOI: 10.1002/jnr.23975] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
312 Weinhold SL, Göder R, Baier PC. Pathway and Effect of Intranasal Orexin. In: Sakurai T, Pandi-perumal S, Monti JM, editors. Orexin and Sleep. Cham: Springer International Publishing; 2015. pp. 339-51. [DOI: 10.1007/978-3-319-23078-8_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
313 Xu R, Wang Q, Yan M, Hernandez M, Gong C, Boon WC, Murata Y, Ueta Y, Chen C. Orexin-A augments voltage-gated Ca2+ currents and synergistically increases growth hormone (GH) secretion with GH-releasing hormone in primary cultured ovine somatotropes. Endocrinology 2002;143:4609-19. [PMID: 12446588 DOI: 10.1210/en.2002-220506] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
314 Bernard R, Lydic R, Baghdoyan HA. Hypocretin-1 activates G proteins in arousal-related brainstem nuclei of rat. Neuroreport 2002;13:447-50. [PMID: 11930158 DOI: 10.1097/00001756-200203250-00017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
315 Huang H, Ghosh P, van den Pol AN. Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal. J Neurophysiol 2006;95:1656-68. [PMID: 16492946 DOI: 10.1152/jn.00927.2005] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 6.8] [Reference Citation Analysis]
316 Li Y, van den Pol AN. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J Neurosci 2005;25:173-83. [PMID: 15634779 DOI: 10.1523/JNEUROSCI.4015-04.2005] [Cited by in Crossref: 76] [Cited by in F6Publishing: 41] [Article Influence: 4.5] [Reference Citation Analysis]
317 Heinonen MV, Purhonen AK, Mäkelä KA, Herzig KH. Functions of orexins in peripheral tissues. Acta Physiol (Oxf) 2008;192:471-85. [PMID: 18294339 DOI: 10.1111/j.1748-1716.2008.01836.x] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 8.9] [Reference Citation Analysis]
318 Ambati A, Luo G, Pradhan E, Louis J, Lin L, Leib RD, Ollila HM, Poiret T, Adams C, Mignot E. Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza Vaccines. Vaccines (Basel) 2020;8:E630. [PMID: 33142956 DOI: 10.3390/vaccines8040630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Valatx JL. Disorders of consciousness: anatomical and physiological mechanisms. Adv Tech Stand Neurosurg 2004;29:3-22. [PMID: 15035335 DOI: 10.1007/978-3-7091-0558-0_1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
320 van den Pol AN, Ghosh PK, Liu RJ, Li Y, Aghajanian GK, Gao XB. Hypocretin (orexin) enhances neuron activity and cell synchrony in developing mouse GFP-expressing locus coeruleus. J Physiol 2002;541:169-85. [PMID: 12015428 DOI: 10.1113/jphysiol.2002.017426] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 5.9] [Reference Citation Analysis]
321 Barb CR, Matteri RL. Orexin-B modulates luteinizing hormone and growth hormone secretion from porcine pituitary cells in culture. Domest Anim Endocrinol 2005;28:331-7. [PMID: 15760673 DOI: 10.1016/j.domaniend.2004.09.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
322 Suzuki H, Hashimoto H, Kawasaki M, Watanabe M, Otsubo H, Ishikura T, Fujihara H, Ohnishi H, Onuma E, Yamada-Okabe H, Takuwa Y, Ogata E, Nakamura T, Ueta Y. Similar changes of hypothalamic feeding-regulating peptides mRNAs and plasma leptin levels in PTHrP-, LIF-secreting tumors-induced cachectic rats and adjuvant arthritic rats. Int J Cancer 2011;128:2215-23. [PMID: 20602340 DOI: 10.1002/ijc.25535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
323 Yamanaka A, Tsujino N, Funahashi H, Honda K, Guan JL, Wang QP, Tominaga M, Goto K, Shioda S, Sakurai T. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun 2002;290:1237-45. [PMID: 11811995 DOI: 10.1006/bbrc.2001.6318] [Cited by in Crossref: 201] [Cited by in F6Publishing: 188] [Article Influence: 10.1] [Reference Citation Analysis]
324 Bian H, Huang L, Li B, Hu Q, Liang X, Tang J, Zhang JH. The arousal effect of hyperbaric oxygen through orexin/hypocretin an upregulation on ketamine/ethanol-induced unconsciousness in male rats. J Neurosci Res 2020;98:201-11. [PMID: 30895638 DOI: 10.1002/jnr.24414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
325 Sakurai T. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis. Sleep Med Rev 2005;9:231-41. [PMID: 15961331 DOI: 10.1016/j.smrv.2004.07.007] [Cited by in Crossref: 196] [Cited by in F6Publishing: 172] [Article Influence: 11.5] [Reference Citation Analysis]
326 Stoyanova II. Ghrelin: a link between ageing, metabolism and neurodegenerative disorders. Neurobiol Dis 2014;72 Pt A:72-83. [PMID: 25173805 DOI: 10.1016/j.nbd.2014.08.026] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
327 Rodgers R, Ishii Y, Halford J, Blundell J. Orexins and appetite regulation. Neuropeptides 2002;36:303-25. [DOI: 10.1016/s0143-4179(02)00085-9] [Cited by in Crossref: 118] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
328 Girault EM, Foppen E, Ackermans MT, Fliers E, Kalsbeek A. Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of Olanzapine on endogenous glucose production. Brain Research 2013;1527:238-45. [DOI: 10.1016/j.brainres.2013.06.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
329 Obukuro K, Nobunaga M, Takigawa M, Morioka H, Hisatsune A, Isohama Y, Shimokawa H, Tsutsui M, Katsuki H. Nitric oxide mediates selective degeneration of hypothalamic orexin neurons through dysfunction of protein disulfide isomerase. J Neurosci 2013;33:12557-68. [PMID: 23904594 DOI: 10.1523/JNEUROSCI.0595-13.2013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
330 Ahmadi-Soleimani SM, Azizi H, Abbasi-Mazar A. Intermittent REM sleep deprivation attenuates the development of morphine tolerance and dependence in male rats. Neurosci Lett 2021;748:135735. [PMID: 33592307 DOI: 10.1016/j.neulet.2021.135735] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
331 Luppi P, Fort P. Neurochemistry of sleep. Sleep Disorders. Elsevier; 2011. pp. 173-90. [DOI: 10.1016/b978-0-444-52006-7.00011-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
332 Jerath R, Harden K, Crawford M, Barnes VA, Jensen M. Role of cardiorespiratory synchronization and sleep physiology: effects on membrane potential in the restorative functions of sleep. Sleep Medicine 2014;15:279-88. [DOI: 10.1016/j.sleep.2013.10.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
333 Abbott SM, Videnovic A. Chronic sleep disturbance and neural injury: links to neurodegenerative disease. Nat Sci Sleep 2016;8:55-61. [PMID: 26869817 DOI: 10.2147/NSS.S78947] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
334 Kukkonen JP, Holmqvist T, Ammoun S, Åkerman KEO. Functions of the orexinergic/hypocretinergic system. American Journal of Physiology-Cell Physiology 2002;283:C1567-91. [DOI: 10.1152/ajpcell.00055.2002] [Cited by in Crossref: 200] [Cited by in F6Publishing: 188] [Article Influence: 10.0] [Reference Citation Analysis]
335 Teske JA, Levine AS, Kuskowski M, Levine JA, Kotz CM. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 2006;291:R889-99. [PMID: 16763079 DOI: 10.1152/ajpregu.00536.2005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
336 Peever JH, Lai YY, Siegel JM. Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 2003;89:2591-600. [PMID: 12611960 DOI: 10.1152/jn.00968.2002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
337 Eggermann E, Bayer L, Serafin M, Saint-Mleux B, Bernheim L, Machard D, Jones BE, Mühlethaler M. The wake-promoting hypocretin-orexin neurons are in an intrinsic state of membrane depolarization. J Neurosci 2003;23:1557-62. [PMID: 12629156 [PMID: 12629156 DOI: 10.1523/jneurosci.23-05-01557.2003] [Cited by in Crossref: 113] [Article Influence: 5.9] [Reference Citation Analysis]
338 Boutrel B, Kenny PJ, Markou A, Koob GF. Hypocretin and Brain Reward Function. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 317-26. [DOI: 10.1007/0-387-25446-3_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
339 da Silva ES, dos Santos TV, Hoeller AA, dos Santos TS, Pereira GV, Meneghelli C, Penzlin AI, dos Santos MM, Faria MS, Paschoalini MA, Marino-neto J. Behavioral and metabolic effects of central injections of orexins/hypocretins in pigeons (Columba livia). Regulatory Peptides 2008;147:9-18. [DOI: 10.1016/j.regpep.2007.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
340 Irving E, Harrison D, Babbs A, Mayes A, Campbell C, Hunter A, Upton N, Parsons A. Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neuroscience Letters 2002;324:53-6. [DOI: 10.1016/s0304-3940(02)00176-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
341 Samson WK, Taylor MM, Ferguson AV. Non-sleep effects of hypocretin/orexin. Sleep Med Rev 2005;9:243-52. [PMID: 16036174 DOI: 10.1016/j.smrv.2004.07.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.8] [Reference Citation Analysis]
342 Kagerer SM, Jöhren O. Interactions of orexins/hypocretins with adrenocortical functions. Acta Physiol (Oxf) 2010;198:361-71. [PMID: 19719797 DOI: 10.1111/j.1748-1716.2009.02034.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
343 Karnani MM, Apergis-Schoute J, Adamantidis A, Jensen LT, de Lecea L, Fugger L, Burdakov D. Activation of central orexin/hypocretin neurons by dietary amino acids. Neuron 2011;72:616-29. [PMID: 22099463 DOI: 10.1016/j.neuron.2011.08.027] [Cited by in Crossref: 99] [Cited by in F6Publishing: 93] [Article Influence: 9.9] [Reference Citation Analysis]
344 Dehkordi O, Rose JE, Dávila-García MI, Millis RM, Mirzaei SA, Manaye KF, Jayam-Trouth A. Neuroanatomical Relationships between Orexin/Hypocretin-Containing Neurons/Nerve Fibers and Nicotine-Induced c-Fos-Activated Cells of the Reward-Addiction Neurocircuitry. J Alcohol Drug Depend 2017;5:273. [PMID: 29038792 DOI: 10.4172/2329-6488.1000273] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
345 Nishino S, Mignot E. Narcolepsy and cataplexy. Sleep Disorders. Elsevier; 2011. pp. 783-814. [DOI: 10.1016/b978-0-444-52007-4.00007-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 2.9] [Reference Citation Analysis]
346 Kiwaki K, Kotz CM, Wang C, Lanningham-Foster L, Levine JA. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 2004;286:E551-9. [PMID: 14656716 DOI: 10.1152/ajpendo.00126.2003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 98] [Article Influence: 5.5] [Reference Citation Analysis]
347 Teske JA, Perez-Leighton CE, Billington CJ, Kotz CM. Role of the locus coeruleus in enhanced orexin A-induced spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 2013;305:R1337-45. [PMID: 24089383 DOI: 10.1152/ajpregu.00229.2013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
348 Meye FJ, Adan RA. Feelings about food: the ventral tegmental area in food reward and emotional eating. Trends Pharmacol Sci 2014;35:31-40. [PMID: 24332673 DOI: 10.1016/j.tips.2013.11.003] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 9.4] [Reference Citation Analysis]
349 Smith KL, Patterson M, Dhillo WS, Patel SR, Semjonous NM, Gardiner JV, Ghatei MA, Bloom SR. Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology 2006;147:3510-8. [PMID: 16574794 DOI: 10.1210/en.2005-1280] [Cited by in Crossref: 138] [Cited by in F6Publishing: 141] [Article Influence: 8.6] [Reference Citation Analysis]
350 Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S, Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 2006;26:398-405. [PMID: 16407535 DOI: 10.1523/JNEUROSCI.2761-05.2006] [Cited by in Crossref: 357] [Cited by in F6Publishing: 172] [Article Influence: 22.3] [Reference Citation Analysis]
351 Taheri S, Sunter D, Dakin C, Moyes S, Seal L, Gardiner J, Rossi M, Ghatei M, Bloom S. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neuroscience Letters 2000;279:109-12. [DOI: 10.1016/s0304-3940(99)00955-6] [Cited by in Crossref: 122] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
352 Huesa G, van den Pol AN, Finger TE. Differential distribution of hypocretin (orexin) and melanin-concentrating hormone in the goldfish brain. J Comp Neurol 2005;488:476-91. [PMID: 15973685 DOI: 10.1002/cne.20610] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 4.5] [Reference Citation Analysis]
353 Rasmussen K, Hsu MA, Yang Y. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy. Neuropsychopharmacology 2007;32:786-92. [PMID: 17063151 DOI: 10.1038/sj.npp.1301239] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.5] [Reference Citation Analysis]
354 Xia J, Chen X, Song C, Ye J, Yu Z, Hu Z. Postsynaptic excitation of prefrontal cortical pyramidal neurons by hypocretin-1/orexin A through the inhibition of potassium currents. J Neurosci Res 2005;82:729-36. [PMID: 16247802 DOI: 10.1002/jnr.20667] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
355 Ahmadi-soleimani SM, Azizi H, Gompf HS, Semnanian S. Role of orexin type-1 receptors in paragiganto-coerulear modulation of opioid withdrawal and tolerance: A site specific focus. Neuropharmacology 2017;126:25-37. [DOI: 10.1016/j.neuropharm.2017.08.024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
356 Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 2004;101:4649-54. [PMID: 15070772 DOI: 10.1073/pnas.0400590101] [Cited by in Crossref: 217] [Cited by in F6Publishing: 193] [Article Influence: 12.1] [Reference Citation Analysis]
357 Schmeichel BE, Berridge CW. Amphetamine acts within the lateral hypothalamic area to elicit affectively neutral arousal and reinstate drug-seeking. Int J Neuropsychopharmacol 2014;17:63-75. [PMID: 23895988 DOI: 10.1017/S1461145713000734] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
358 Cluderay JE, Harrison DC, Hervieu GJ. Protein distribution of the orexin-2 receptor in the rat central nervous system. Regul Pept 2002;104:131-44. [PMID: 11830288 DOI: 10.1016/s0167-0115(01)00357-3] [Cited by in Crossref: 198] [Cited by in F6Publishing: 65] [Article Influence: 9.9] [Reference Citation Analysis]
359 Simpson KA, Martin NM, Bloom SR. Hypothalamic regulation of appetite. Expert Review of Endocrinology & Metabolism 2014;3:577-92. [DOI: 10.1586/17446651.3.5.577] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
360 Álvarez-Crespo M, Martínez-Sánchez N, Ruíz-Pino F, Garcia-Lavandeira M, Alvarez CV, Tena-Sempere M, Nogueiras R, Diéguez C, López M. The orexigenic effect of orexin-A revisited: dependence of an intact growth hormone axis. Endocrinology 2013;154:3589-98. [PMID: 23861376 DOI: 10.1210/en.2013-1251] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
361 Doane DF, Lawson MA, Meade JR, Kotz CM, Beverly JL. Orexin-induced feeding requires NMDA receptor activation in the perifornical region of the lateral hypothalamus. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2007;293:R1022-6. [DOI: 10.1152/ajpregu.00282.2007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
362 Ferguson AV, Samson WK. The orexin/hypocretin system: a critical regulator of neuroendocrine and autonomic function. Frontiers in Neuroendocrinology 2003;24:141-50. [DOI: 10.1016/s0091-3022(03)00028-1] [Cited by in Crossref: 133] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
363 España RA, Baldo BA, Kelley AE, Berridge CW. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action. Neuroscience 2001;106:699-715. [PMID: 11682157 DOI: 10.1016/s0306-4522(01)00319-0] [Cited by in Crossref: 218] [Cited by in F6Publishing: 95] [Article Influence: 10.9] [Reference Citation Analysis]
364 Collier DA. News in Brief. Mol Psychiatry 2000;5:9-10. [DOI: 10.1038/sj.mp.4000715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
365 Bateman JT, Saunders SE, Levitt ES. Understanding and countering opioid-induced respiratory depression. Br J Pharmacol 2021. [PMID: 34089181 DOI: 10.1111/bph.15580] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Sakurai T. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regulatory Peptides 2005;126:3-10. [DOI: 10.1016/j.regpep.2004.08.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
367 Kourosh-arami M, Javan M, Semnanian S. Inhibition of orexin receptor 1 contributes to the development of morphine dependence via attenuation of cAMP response element-binding protein and phospholipase Cβ3. Journal of Chemical Neuroanatomy 2020;108:101801. [DOI: 10.1016/j.jchemneu.2020.101801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
368 Katayama S, Hamasu K, Shigemi K, Cline M, Furuse M. Intracerebroventricular injection of orexin-A, but not orexin-B, induces arousal of layer-type neonatal chicks. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2010;157:132-5. [DOI: 10.1016/j.cbpa.2010.05.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
369 Volgin DV, Lu JW, Stettner GM, Mann GL, Ross RJ, Morrison AR, Kubin L. Time- and behavioral state-dependent changes in posterior hypothalamic GABAA receptors contribute to the regulation of sleep. PLoS One 2014;9:e86545. [PMID: 24466145 DOI: 10.1371/journal.pone.0086545] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
370 Simmons SJ, Martorana R, Philogene-Khalid H, Tran FH, Gentile TA, Xu X, Su S, Rawls SM, Muschamp JW. Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats. Psychopharmacology (Berl) 2017;234:3207-15. [PMID: 28786030 DOI: 10.1007/s00213-017-4709-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
371 Sasaki K, Suzuki M, Mieda M, Tsujino N, Roth B, Sakurai T. Pharmacogenetic modulation of orexin neurons alters sleep/wakefulness states in mice. PLoS One 2011;6:e20360. [PMID: 21647372 DOI: 10.1371/journal.pone.0020360] [Cited by in Crossref: 152] [Cited by in F6Publishing: 157] [Article Influence: 13.8] [Reference Citation Analysis]
372 Imperatore R, Palomba L, Cristino L. Role of Orexin-A in Hypertension and Obesity. Curr Hypertens Rep 2017;19. [DOI: 10.1007/s11906-017-0729-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
373 Branch AF, Navidi W, Tabuchi S, Terao A, Yamanaka A, Scammell TE, Diniz Behn C. Progressive Loss of the Orexin Neurons Reveals Dual Effects on Wakefulness. Sleep 2016;39:369-77. [PMID: 26446125 DOI: 10.5665/sleep.5446] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
374 de Lecea L. Optogenetic control of hypocretin (orexin) neurons and arousal circuits. Curr Top Behav Neurosci 2015;25:367-78. [PMID: 25502546 DOI: 10.1007/7854_2014_364] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
375 Asakawa A, Inui A, Inui T, Katsuura G, Fujino MA, Kasuga M. Orexin reverses cholecystokinin-induced reduction in feeding. Diabetes Obes Metab. 2002;4:399-401. [PMID: 12406038 DOI: 10.1046/j.1463-1326.2002.00234.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
376 Gompf H, Chen J, Sun Y, Yanagisawa M, Aston-Jones G, Kelz MB. Halothane-induced hypnosis is not accompanied by inactivation of orexinergic output in rodents. Anesthesiology 2009;111:1001-9. [PMID: 19809293 DOI: 10.1097/ALN.0b013e3181b764b3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
377 Kawashima M, Tamiya G, Oka A, Hohjoh H, Juji T, Ebisawa T, Honda Y, Inoko H, Tokunaga K. Genomewide association analysis of human narcolepsy and a new resistance gene. Am J Hum Genet 2006;79:252-63. [PMID: 16826516 DOI: 10.1086/505539] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
378 López JM, Sanz-Morello B, González A. Organization of the orexin/hypocretin system in the brain of two basal actinopterygian fishes, the cladistians Polypterus senegalus and Erpetoichthys calabaricus. Peptides 2014;61:23-37. [PMID: 25169954 DOI: 10.1016/j.peptides.2014.08.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
379 Xia J, Chen X, Cheng S, Hu Z. Mechanisms of orexin A-evoked changes of intracellular calcium in primary cultured cortical neurons: . NeuroReport 2005;16:783-6. [DOI: 10.1097/00001756-200505120-00025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
380 Cutler DJ, Morris R, Evans ML, Leslie RA, Arch JR, Williams G. Orexin-A immunoreactive neurons in the rat hypothalamus do not contain neuronal nitric oxide synthase (nNOS). Peptides 2001;22:123-8. [DOI: 10.1016/s0196-9781(00)00364-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
381 Weinhold SL, Seeck-Hirschner M, Nowak A, Hallschmid M, Göder R, Baier PC. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy. Behav Brain Res 2014;262:8-13. [PMID: 24406723 DOI: 10.1016/j.bbr.2013.12.045] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
382 Alam MN, Gong H, Alam T, Jaganath R, McGinty D, Szymusiak R. Sleep-waking discharge patterns of neurons recorded in the rat perifornical lateral hypothalamic area. J Physiol. 2002;538:619-631. [PMID: 11790824 DOI: 10.1113/jphysiol.2001.012888] [Cited by in Crossref: 129] [Cited by in F6Publishing: 119] [Article Influence: 6.5] [Reference Citation Analysis]
383 Li Y, Gao X, Sakurai T, van den Pol AN. Hypocretin/Orexin Excites Hypocretin Neurons via a Local Glutamate Neuron—A Potential Mechanism for Orchestrating the Hypothalamic Arousal System. Neuron 2002;36:1169-81. [DOI: 10.1016/s0896-6273(02)01132-7] [Cited by in Crossref: 300] [Cited by in F6Publishing: 162] [Article Influence: 15.0] [Reference Citation Analysis]
384 Keating GL, Kuhar MJ, Bliwise DL, Rye DB. Wake promoting effects of cocaine and amphetamine-regulated transcript (CART). Neuropeptides 2010;44:241-6. [PMID: 20116848 DOI: 10.1016/j.npep.2009.12.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
385 Imperatore R, Cristino L. Role of Orexin-B/Orexin 2 receptor in myocardial protection. Clinical Science 2019;133:853-7. [DOI: 10.1042/cs20181036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
386 De la Herrán-arita AK, Drucker-colín R. Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery 2012;7:155-64. [DOI: 10.1517/17460441.2012.651454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
387 Ahnaou A, Drinkenburg W. Neuropeptide-S Evoked Arousal with Electroencephalogram Slow-Wave Compensatory Drive in Rats. Neuropsychobiology 2012;65:195-205. [DOI: 10.1159/000336998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
388 Reinscheid RK, Xu Y. Neuropeptide S as a novel arousal promoting peptide transmitter: NPS produces arousal and anxiolysis. FEBS Journal 2005;272:5689-93. [DOI: 10.1111/j.1742-4658.2005.04982.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 2.6] [Reference Citation Analysis]
389 Otake K, Kin K, Nakamura Y. Fos expression in afferents to the rat midline thalamus following immobilization stress. Neurosci Res 2002;43:269-82. [PMID: 12103445 DOI: 10.1016/s0168-0102(02)00042-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
390 Gao XB, Hermes G. Neural plasticity in hypocretin neurons: the basis of hypocretinergic regulation of physiological and behavioral functions in animals. Front Syst Neurosci 2015;9:142. [PMID: 26539086 DOI: 10.3389/fnsys.2015.00142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
391 Del Cid-Pellitero E, Jones BE. Immunohistochemical evidence for synaptic release of GABA from melanin-concentrating hormone containing varicosities in the locus coeruleus. Neuroscience 2012;223:269-76. [PMID: 22890079 DOI: 10.1016/j.neuroscience.2012.07.072] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
392 Igarashi N, Tatsumi K, Nakamura A, Sakao S, Takiguchi Y, Nishikawa T, Kuriyama T. Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome. Chest 2003;124:1381-5. [PMID: 14555569 DOI: 10.1378/chest.124.4.1381] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
393 Godden KE, Landry JP, Slepneva N, Migues PV, Pompeiano M. Early expression of hypocretin/orexin in the chick embryo brain. PLoS One 2014;9:e106977. [PMID: 25188307 DOI: 10.1371/journal.pone.0106977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
394 Yang C, Zhang L, Hao H, Ran M, Li J, Dong H. Serotonergic neurons in the dorsal raphe nucleus mediate the arousal-promoting effect of orexin during isoflurane anesthesia in male rats. Neuropeptides 2019;75:25-33. [DOI: 10.1016/j.npep.2019.03.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
395 Goadsby PJ. Can we Develop Neurally Acting Drugs for the Treatment of Migraine? Nat Rev Drug Discov 2005;4:741-50. [DOI: 10.1038/nrd1822] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
396 España RA, Oleson EB, Locke JL, Brookshire BR, Roberts DC, Jones SR. The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system. Eur J Neurosci 2010;31:336-48. [PMID: 20039943 DOI: 10.1111/j.1460-9568.2009.07065.x] [Cited by in Crossref: 165] [Cited by in F6Publishing: 162] [Article Influence: 12.7] [Reference Citation Analysis]
397 Wang J, Osaka T, Inoue S. Orexin-A-sensitive site for energy expenditure localized in the arcuate nucleus of the hypothalamus. Brain Research 2003;971:128-34. [DOI: 10.1016/s0006-8993(03)02437-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
398 Sandsmark DK, Elliott JE, Lim MM. Sleep-Wake Disturbances After Traumatic Brain Injury: Synthesis of Human and Animal Studies. Sleep 2017;40. [PMID: 28329120 DOI: 10.1093/sleep/zsx044] [Cited by in Crossref: 32] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
399 Ishibashi M, Takano S, Yanagida H, Takatsuna M, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Effects of orexins/hypocretins on neuronal activity in the paraventricular nucleus of the thalamus in rats in vitro. Peptides 2005;26:471-81. [PMID: 15652654 DOI: 10.1016/j.peptides.2004.10.014] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
400 de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol. 2014;5:16. [PMID: 24575043 DOI: 10.3389/fphar.2014.00016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
401 Grafe LA, Bhatnagar S. Orexins and stress. Front Neuroendocrinol 2018;51:132-45. [PMID: 29932958 DOI: 10.1016/j.yfrne.2018.06.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
402 Sato-suzuki I, Kita I, Seki Y, Oguri M, Arita H. Cortical arousal induced by microinjection of orexins into the paraventricular nucleus of the rat. Behavioural Brain Research 2002;128:169-77. [DOI: 10.1016/s0166-4328(01)00307-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
403 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
404 González JA, Jensen LT, Iordanidou P, Strom M, Fugger L, Burdakov D. Inhibitory Interplay between Orexin Neurons and Eating. Curr Biol 2016;26:2486-91. [PMID: 27546579 DOI: 10.1016/j.cub.2016.07.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 10.5] [Reference Citation Analysis]
405 Bernstein DL, Badve PS, Barson JR, Bass CE, España RA. Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine. Addict Biol 2018;23:1032-45. [PMID: 28971565 DOI: 10.1111/adb.12553] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
406 Davis SF, Williams KW, Xu W, Glatzer NR, Smith BN. Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation. J Neurosci 2003;23:3844-54. [PMID: 12736355 [PMID: 12736355 DOI: 10.1523/jneurosci.23-09-03844.2003] [Cited by in Crossref: 63] [Article Influence: 3.3] [Reference Citation Analysis]
407 Patton DF, Mistlberger RE. Circadian adaptations to meal timing: neuroendocrine mechanisms. Front Neurosci. 2013;7:185. [PMID: 24133410 DOI: 10.3389/fnins.2013.00185] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 11.1] [Reference Citation Analysis]
408 Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci 2001;4:732-8. [PMID: 11426230 DOI: 10.1038/89522] [Cited by in Crossref: 396] [Cited by in F6Publishing: 365] [Article Influence: 18.9] [Reference Citation Analysis]
409 Mintz EM, van den Pol AN, Casano AA, Albers H. Distribution of hypocretin-(orexin) immunoreactivity in the central nervous system of Syrian hamsters (Mesocricetus auratus). Journal of Chemical Neuroanatomy 2001;21:225-38. [DOI: 10.1016/s0891-0618(01)00111-9] [Cited by in Crossref: 73] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
410 Stoyanova II, Rutten WL, le Feber J. Orexin-A and orexin-B during the postnatal development of the rat brain. Cell Mol Neurobiol 2010;30:81-9. [PMID: 19633949 DOI: 10.1007/s10571-009-9433-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
411 Chase MH. A unified survival theory of the functioning of the hypocretinergic system. J Appl Physiol (1985) 2013;115:954-71. [PMID: 23640599 DOI: 10.1152/japplphysiol.00700.2012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
412 Koob GF, Colrain IM. Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework. Neuropsychopharmacology 2020;45:141-65. [PMID: 31234199 DOI: 10.1038/s41386-019-0446-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 12.3] [Reference Citation Analysis]
413 Kallupi M, Cannella N, Economidou D, Ubaldi M, Ruggeri B, Weiss F, Massi M, Marugan J, Heilig M, Bonnavion P, de Lecea L, Ciccocioppo R. Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system. Proc Natl Acad Sci U S A 2010;107:19567-72. [PMID: 20974945 DOI: 10.1073/pnas.1004100107] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 5.3] [Reference Citation Analysis]
414 Ortega JE, Katner J, Davis R, Wade M, Nisenbaum L, Nomikos GG, Svensson KA, Perry KW. Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: a microdialysis study. J Neurosci Res 2012;90:588-96. [PMID: 22038504 DOI: 10.1002/jnr.22781] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
415 Franks NP, Zecharia AY. Sleep and general anesthesia. Can J Anaesth 2011;58:139-48. [PMID: 21170623 DOI: 10.1007/s12630-010-9420-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
416 Kim AK, Brown RM, Lawrence AJ. The role of orexins/hypocretins in alcohol use and abuse: an appetitive-reward relationship. Front Behav Neurosci 2012;6:78. [PMID: 23189046 DOI: 10.3389/fnbeh.2012.00078] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
417 Yamanaka A, Muraki Y, Ichiki K, Tsujino N, Kilduff TS, Goto K, Sakurai T. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J Neurophysiol 2006;96:284-98. [PMID: 16611835 DOI: 10.1152/jn.01361.2005] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 4.9] [Reference Citation Analysis]
418 Mochizuki T, Klerman EB, Sakurai T, Scammell TE. Elevated body temperature during sleep in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 2006;291:R533-40. [PMID: 16556901 DOI: 10.1152/ajpregu.00887.2005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
419 Inutsuka A, Yamashita A, Chowdhury S, Nakai J, Ohkura M, Taguchi T, Yamanaka A. The integrative role of orexin/hypocretin neurons in nociceptive perception and analgesic regulation. Sci Rep 2016;6:29480. [PMID: 27385517 DOI: 10.1038/srep29480] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 10.3] [Reference Citation Analysis]
420 Toyama S, Shimoyama N, Tagaito Y, Nagase H, Saitoh T, Yanagisawa M, Shimoyama M. Nonpeptide Orexin-2 Receptor Agonist Attenuates Morphine-induced Sedative Effects in Rats. Anesthesiology 2018;128:992-1003. [PMID: 29521652 DOI: 10.1097/ALN.0000000000002161] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
421 Shimizu S, Takenoshita N, Inagawa Y, Tsugawa A, Hirose D, Kaneko Y, Ogawa Y, Serisawa S, Sakurai S, Hirao K, Kanetaka H, Kanbayashi T, Imanishi A, Sakurai H, Hanyu H. Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer’s Disease. JAD 2020;73:117-23. [DOI: 10.3233/jad-190958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
422 Higuchi S, Usui A, Murasaki M, Matsushita S, Nishioka N, Yoshino A, Matsui T, Muraoka H, Ishizuka Y, Kanba S, Sakurai T. Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett 2002;318:61-4. [PMID: 11796186 DOI: 10.1016/s0304-3940(01)02476-4] [Cited by in Crossref: 63] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
423 Franceschini C, Pizza F, Cavalli F, Plazzi G. A practical guide to the pharmacological and behavioral therapy of Narcolepsy. Neurotherapeutics 2021;18:6-19. [PMID: 33886090 DOI: 10.1007/s13311-021-01051-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
424 Darker JG, Porter RA, Eggleston DS, Smart D, Brough SJ, Sabido-david C, Jerman JC. Structure–activity analysis of truncated orexin-A analogues at the orexin-1 receptor. Bioorganic & Medicinal Chemistry Letters 2001;11:737-40. [DOI: 10.1016/s0960-894x(01)00043-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
425 Baier PC, Hallschmid M, Seeck-Hirschner M, Weinhold SL, Burkert S, Diessner N, Göder R, Aldenhoff JB, Hinze-Selch D. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy. Sleep Med 2011;12:941-6. [PMID: 22036605 DOI: 10.1016/j.sleep.2011.06.015] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
426 Bonert VS, Melmed S. Growth Hormone. The Pituitary. Elsevier; 2017. pp. 85-127. [DOI: 10.1016/b978-0-12-804169-7.00004-0] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
427 Fadel J, Deutch A. Anatomical substrates of orexin–dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002;111:379-87. [DOI: 10.1016/s0306-4522(02)00017-9] [Cited by in Crossref: 346] [Cited by in F6Publishing: 171] [Article Influence: 17.3] [Reference Citation Analysis]
428 Kawada Y, Ueno S, Asayama K, Tsutsui M, Utsunomiya K, Toyohira Y, Morisada N, Tanaka K, Shirahata A, Yanagihara N. Stimulation of catecholamine synthesis by orexin-A in bovine adrenal medullary cells through orexin receptor 1. Biochem Pharmacol. 2003;66:141-147. [PMID: 12818374 DOI: 10.1016/S0006-2952(03)00236-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
429 Thakkar MM, Winston S, McCarley RW. Orexin neurons of the hypothalamus express adenosine A1 receptors. Brain Res 2002;944:190-4. [PMID: 12106679 DOI: 10.1016/s0006-8993(02)02873-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
430 Langmead CJ, Jerman JC, Brough SJ, Scott C, Porter RA, Herdon HJ. Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor. Br J Pharmacol 2004;141:340-6. [PMID: 14691055 DOI: 10.1038/sj.bjp.0705610] [Cited by in Crossref: 110] [Cited by in F6Publishing: 94] [Article Influence: 5.8] [Reference Citation Analysis]
431 Farr SA, Banks WA, Kumar VB, Morley JE. Orexin-A-induced feeding is dependent on nitric oxide. Peptides 2005;26:759-65. [DOI: 10.1016/j.peptides.2004.12.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
432 Blanco-Centurion C, Gerashchenko D, Salin-Pascual RJ, Shiromani PJ. Effects of hypocretin2-saporin and antidopamine-beta-hydroxylase-saporin neurotoxic lesions of the dorsolateral pons on sleep and muscle tone. Eur J Neurosci 2004;19:2741-52. [PMID: 15147308 DOI: 10.1111/j.0953-816X.2004.03366.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
433 Rosenwasser AM. Functional neuroanatomy of sleep and circadian rhythms. Brain Res Rev 2009;61:281-306. [PMID: 19695288 DOI: 10.1016/j.brainresrev.2009.08.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
434 Emamzadeh FN, Surguchov A. Parkinson's Disease: Biomarkers, Treatment, and Risk Factors. Front Neurosci 2018;12:612. [PMID: 30214392 DOI: 10.3389/fnins.2018.00612] [Cited by in Crossref: 129] [Cited by in F6Publishing: 101] [Article Influence: 32.3] [Reference Citation Analysis]
435 Zeitzer JM, Buckmaster CL, Landolt HP, Lyons DM, Mignot E. Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep. Behav Pharmacol 2009;20:643-52. [PMID: 19752724 DOI: 10.1097/FBP.0b013e328331b9db] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
436 Muroya S, Uramura K, Sakurai T, Takigawa M, Yada T. Lowering glucose concentrations increases cytosolic Ca2+ in orexin neurons of the rat lateral hypothalamus. Neuroscience Letters 2001;309:165-8. [DOI: 10.1016/s0304-3940(01)02053-5] [Cited by in Crossref: 52] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
437 Matzeu A, Martin-Fardon R. Targeting the Orexin System for Prescription Opioid Use Disorder. Brain Sci 2020;10:E226. [PMID: 32290110 DOI: 10.3390/brainsci10040226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
438 Parsons MP, Li S, Kirouac GJ. Functional and anatomical connection between the paraventricular nucleus of the thalamus and dopamine fibers of the nucleus accumbens. J Comp Neurol 2007;500:1050-63. [PMID: 17183538 DOI: 10.1002/cne.21224] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 6.4] [Reference Citation Analysis]
439 Li JX, Yoshida T, Monk KJ, Katz DB. Lateral hypothalamus contains two types of palatability-related taste responses with distinct dynamics. J Neurosci 2013;33:9462-73. [PMID: 23719813 DOI: 10.1523/JNEUROSCI.3935-12.2013] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
440 Duncan MJ, Franklin KM, Peng X, Yun C, Legan SJ. Circadian rhythm disruption by a novel running wheel: roles of exercise and arousal in blockade of the luteinizing hormone surge. Physiol Behav 2014;131:7-16. [PMID: 24727338 DOI: 10.1016/j.physbeh.2014.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
441 Xue Y, Yang YT, Liu HY, Chen WF, Chen AQ, Sheng Q, Chen XY, Wang Y, Chen H, Liu HX, Pang YY, Chen L. Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats. Eur J Neurosci 2016;44:2247-57. [PMID: 27336845 DOI: 10.1111/ejn.13323] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
442 Milbank E, López M. Orexins/Hypocretins: Key Regulators of Energy Homeostasis. Front Endocrinol (Lausanne) 2019;10:830. [PMID: 31920958 DOI: 10.3389/fendo.2019.00830] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
443 Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacol Rev 2018;70:197-245. [PMID: 29487083 DOI: 10.1124/pr.117.014381] [Cited by in Crossref: 89] [Cited by in F6Publishing: 57] [Article Influence: 22.3] [Reference Citation Analysis]
444 Dugovic C, Shelton JE, Aluisio LE, Fraser IC, Jiang X, Sutton SW, Bonaventure P, Yun S, Li X, Lord B, Dvorak CA, Carruthers NI, Lovenberg TW. Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat. J Pharmacol Exp Ther 2009;330:142-51. [PMID: 19363060 DOI: 10.1124/jpet.109.152009] [Cited by in Crossref: 150] [Cited by in F6Publishing: 154] [Article Influence: 11.5] [Reference Citation Analysis]
445 García-Brito S, Aldavert-Vera L, Huguet G, Kádár E, Segura-Torres P. Orexin-1 receptor blockade differentially affects spatial and visual discrimination memory facilitation by intracranial self-stimulation. Neurobiol Learn Mem 2020;169:107188. [PMID: 32061874 DOI: 10.1016/j.nlm.2020.107188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
446 Surendran S, Rady PL, Szucs S, Michals-matalon K, Tyring SK, Matalon R. High level of orexin A observed in the phenylketonuria mouse brain is due to the abnormal expression of prepro-orexin. Biochemical and Biophysical Research Communications 2004;317:522-6. [DOI: 10.1016/j.bbrc.2004.03.079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
447 Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, Mignot E, Nishino S. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities: Hypocretin release during the sleep-wake cycle. European Journal of Neuroscience 2001;14:1075-81. [DOI: 10.1046/j.0953-816x.2001.01725.x] [Cited by in Crossref: 304] [Cited by in F6Publishing: 278] [Article Influence: 14.5] [Reference Citation Analysis]
448 Inocente CO, Gustin MP, Lavault S, Guignard-Perret A, Raoux A, Christol N, Gerard D, Dauvilliers Y, Reimão R, Bat-Pitault F, Lin JS, Arnulf I, Lecendreux M, Franco P. Depressive feelings in children with narcolepsy. Sleep Med 2014;15:309-14. [PMID: 24503472 DOI: 10.1016/j.sleep.2013.08.798] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
449 Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS, Saper CB. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J Neurosci 2000;20:8620-8. [PMID: 11069971 [PMID: 11069971 DOI: 10.1523/jneurosci.20-22-08620.2000] [Cited by in Crossref: 321] [Article Influence: 15.3] [Reference Citation Analysis]
450 Gottschalk MG, Richter J, Ziegler C, Schiele MA, Mann J, Geiger MJ, Schartner C, Homola GA, Alpers GW, Büchel C, Fehm L, Fydrich T, Gerlach AL, Gloster AT, Helbig-Lang S, Kalisch R, Kircher T, Lang T, Lonsdorf TB, Pané-Farré CA, Ströhle A, Weber H, Zwanzger P, Arolt V, Romanos M, Wittchen HU, Hamm A, Pauli P, Reif A, Deckert J, Neufang S, Höfler M, Domschke K. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes. Transl Psychiatry 2019;9:75. [PMID: 30718541 DOI: 10.1038/s41398-019-0415-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
451 Aksu K, Güven SF, Aksu F, Ciftci B, Ciftci TU, Aksaray S, Şipit T, Peker Y. Obstructive Sleep Apnoea, Cigarette Smoking and Plasma Orexin-A in a Sleep Clinic Cohort. J Int Med Res 2009;37:331-40. [DOI: 10.1177/147323000903700207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
452 Nakamura T, Uramura K, Nambu T, Yada T, Goto K, Yanagisawa M, Sakurai T. Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 2000;873:181-187. [PMID: 10915829 DOI: 10.1016/S0006-8993(00)02555-5] [Cited by in Crossref: 231] [Cited by in F6Publishing: 73] [Article Influence: 10.5] [Reference Citation Analysis]
453 Mavanji V, Perez-Leighton CE, Kotz CM, Billington CJ, Parthasarathy S, Sinton CM, Teske JA. Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area. Sleep 2015;38:1361-70. [PMID: 25845696 DOI: 10.5665/sleep.4970] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
454 Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, Naghdi N, Yanai K. Enhanced antinociception by intracerebroventricularly administered orexin A in histamine H1 or H2 receptor gene knockout mice. Pain 2005;118:254-62. [DOI: 10.1016/j.pain.2005.08.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
455 Eriksson KS, Sergeeva OA, Selbach O, Haas HL. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons. Eur J Neurosci 2004;19:1278-84. [PMID: 15016085 DOI: 10.1111/j.1460-9568.2004.03243.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 75] [Article Influence: 4.2] [Reference Citation Analysis]
456 Jalal B. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug. Psychopharmacology (Berl) 2018;235:3083-91. [PMID: 30288594 DOI: 10.1007/s00213-018-5042-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
457 Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, Mouri T. Immunoreactive orexin-A in human plasma. Peptides. 2001;22:139-142. [PMID: 11179609 DOI: 10.1016/S0196-9781(00)00369-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
458 Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M, Jeffrey P, Cutler L, Riba I, Johns A, Porter RA, Upton N, Hunter AJ, Parsons AA. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001;92:81-90. [PMID: 11323129 DOI: 10.1016/s0304-3959(00)00470-x] [Cited by in Crossref: 193] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
459 Teske JA, Billington CJ, Kotz CM. Hypocretin/orexin and energy expenditure. Acta Physiol (Oxf) 2010;198:303-12. [PMID: 20070282 DOI: 10.1111/j.1748-1716.2010.02075.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
460 Parsons MP, Hirasawa M. ATP-sensitive potassium channel-mediated lactate effect on orexin neurons: implications for brain energetics during arousal. J Neurosci 2010;30:8061-70. [PMID: 20554857 DOI: 10.1523/JNEUROSCI.5741-09.2010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
461 Tsunematsu T, Tabuchi S, Tanaka KF, Boyden ES, Tominaga M, Yamanaka A. Long-lasting silencing of orexin/hypocretin neurons using archaerhodopsin induces slow-wave sleep in mice. Behav Brain Res 2013;255:64-74. [PMID: 23707248 DOI: 10.1016/j.bbr.2013.05.021] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
462 Sharf R, Sarhan M, Brayton CE, Guarnieri DJ, Taylor JR, DiLeone RJ. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol Psychiatry 2010;67:753-60. [PMID: 20189166 DOI: 10.1016/j.biopsych.2009.12.035] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.2] [Reference Citation Analysis]
463 Fabris C, Cozzi B, Hay-schmidt A, Naver B, Møller M. Demonstration of an orexinergic central innervation of the pineal gland of the pig: Orexinergic System in the Pig Brain. J Comp Neurol 2004;471:113-27. [DOI: 10.1002/cne.20007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
464 Jöhren O, Brüggemann N, Dendorfer A, Dominiak P. Gonadal Steroids Differentially Regulate the Messenger Ribonucleic Acid Expression of Pituitary Orexin Type 1 Receptors and Adrenal Orexin Type 2 Receptors. Endocrinology 2003;144:1219-25. [DOI: 10.1210/en.2002-0030] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
465 van den Pol AN. Physiological Characteristics of Hypocretin/Orexin Neurons. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 123-36. [DOI: 10.1007/0-387-25446-3_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
466 Arihara Z, Takahashi K, Murakami O, Totsune K, Sone M, Satoh F, Ito S, Hayashi Y, Sasano H, Mouri T. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides 2000;21:565-70. [DOI: 10.1016/s0196-9781(00)00184-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
467 Bonnavion P, Jackson AC, Carter ME, de Lecea L. Antagonistic interplay between hypocretin and leptin in the lateral hypothalamus regulates stress responses. Nat Commun 2015;6:6266. [PMID: 25695914 DOI: 10.1038/ncomms7266] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 13.0] [Reference Citation Analysis]
468 Volkoff H. Sleep and Orexins in Nonmammalian Vertebrates. Sleep Hormones. Elsevier; 2012. pp. 315-39. [DOI: 10.1016/b978-0-12-394623-2.00017-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
469 Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, Elmquist JK. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 2001;435:6-25. [PMID: 11370008 DOI: 10.1002/cne.1190] [Cited by in Crossref: 1089] [Cited by in F6Publishing: 1066] [Article Influence: 51.9] [Reference Citation Analysis]
470 Brodnik ZD, Bernstein DL, Prince CD, España RA. Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep. Behav Brain Res 2015;291:377-84. [PMID: 26049058 DOI: 10.1016/j.bbr.2015.05.051] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
471 Gartlon J, Szekeres P, Pullen M, Sarau HM, Aiyar N, Shabon U, Michalovich D, Steplewski K, Ellis C, Elshourbagy N, Duxon M, Ashmeade TE, Harrison DC, Murdock P, Wilson S, Ennaceur A, Atkins A, Heidbreder C, Hagan JJ, Hunter AJ, Jones DN. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology (Berl) 2004;177:1-14. [PMID: 15205870 DOI: 10.1007/s00213-004-1918-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
472 Kok SW, Roelfsema F, Overeem S, Lammers GJ, Frölich M, Meinders AE, Pijl H. Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2004;287:E630-6. [PMID: 15172887 DOI: 10.1152/ajpendo.00060.2004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
473 Zhao P, You Y, Wang Z, Zhou Y, Chai G, Yan G, Jin Z, Wang Q, Sun H. Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice. Brain Struct Funct. [DOI: 10.1007/s00429-021-02447-w] [Reference Citation Analysis]
474 Pan L, Qi R, Wang J, Zhou W, Liu J, Cai Y. Evidence for a Role of Orexin/Hypocretin System in Vestibular Lesion-Induced Locomotor Abnormalities in Rats. Front Neurosci 2016;10:355. [PMID: 27507932 DOI: 10.3389/fnins.2016.00355] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
475 Nixon JP, Smale L. Orexin fibers form appositions with Fos expressing neuropeptide-Y cells in the grass rat intergeniculate leaflet. Brain Research 2005;1053:33-7. [DOI: 10.1016/j.brainres.2005.06.043] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
476 Eggermann E, Serafin M, Bayer L, Machard D, Saint-Mleux B, Jones BE, Mühlethaler M. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 2001;108:177-81. [PMID: 11734353 DOI: 10.1016/s0306-4522(01)00512-7] [Cited by in Crossref: 200] [Cited by in F6Publishing: 83] [Article Influence: 10.0] [Reference Citation Analysis]
477 Fujisawa S, Komatsubara M, Ogura-Ochi K, Tsukamoto-Yamauchi N, Toma K, Inagaki K, Wada J, Otsuka F. Orexin A modulates prolactin production by regulating BMP-4 activity in rat pituitary lactotorope cells. Peptides 2019;113:35-40. [PMID: 30721716 DOI: 10.1016/j.peptides.2019.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
478 Brown JA, Woodworth HL, Leinninger GM. To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci 2015;9:9. [PMID: 25741247 DOI: 10.3389/fnsys.2015.00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
479 Di Giovanni G, Chagraoui A, Puginier E, Galati S, De Deurwaerdère P. Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA. Neurobiol Dis 2019;128:9-18. [PMID: 30149181 DOI: 10.1016/j.nbd.2018.08.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
480 Harthoorn LF, Sane A, Nethe M, Van Heerikhuize JJ. Multi-transcriptional profiling of melanin-concentrating hormone and orexin-containing neurons. Cell Mol Neurobiol. 2005;25:1209-1223. [PMID: 16388333 DOI: 10.1007/s10571-005-8184-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 4.3] [Reference Citation Analysis]
481 Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 2005;102:19168-73. [PMID: 16357203 DOI: 10.1073/pnas.0507480102] [Cited by in Crossref: 354] [Cited by in F6Publishing: 361] [Article Influence: 20.8] [Reference Citation Analysis]
482 Bernard R, Lydic R, Baghdoyan HA. Hypocretin-1 causes G protein activation and increases ACh release in rat pons. Eur J Neurosci 2003;18:1775-85. [PMID: 14622212 DOI: 10.1046/j.1460-9568.2003.02905.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
483 Roch C, Bergamini G, Steiner MA, Clozel M. Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology (Berl) 2021;238:2693-708. [PMID: 34415378 DOI: 10.1007/s00213-021-05954-0] [Reference Citation Analysis]
484 Jia X, Yan J, Xia J, Xiong J, Wang T, Chen Y, Qi A, Yang N, Fan S, Ye J, Hu Z. Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats. Neuropharmacology 2012;62:775-83. [PMID: 21924278 DOI: 10.1016/j.neuropharm.2011.08.047] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
485 Mavanji V, Billington CJ, Kotz CM, Teske JA. Sleep and obesity: a focus on animal models. Neurosci Biobehav Rev 2012;36:1015-29. [PMID: 22266350 DOI: 10.1016/j.neubiorev.2012.01.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
486 Morshedi MM, Meredith GE. Repeated amphetamine administration induces Fos in prefrontal cortical neurons that project to the lateral hypothalamus but not the nucleus accumbens or basolateral amygdala. Psychopharmacology (Berl) 2008;197:179-89. [PMID: 18080115 DOI: 10.1007/s00213-007-1021-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
487 Ferry B. The orexinergic system influences conditioned odor aversion learning in the rat: a theory on the processes and hypothesis on the circuit involved. Front Behav Neurosci 2014;8:164. [PMID: 24834041 DOI: 10.3389/fnbeh.2014.00164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
488 Conrad KL, Davis AR, Silberman Y, Sheffler DJ, Shields AD, Saleh SA, Sen N, Matthies HJ, Javitch JA, Lindsley CW, Winder DG. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Neuropsychopharmacology 2012;37:2253-66. [PMID: 22617356 DOI: 10.1038/npp.2012.76] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
489 Tang F, Lane S, Korsak A, Paton JF, Gourine AV, Kasparov S, Teschemacher AG. Lactate-mediated glia-neuronal signalling in the mammalian brain. Nat Commun 2014;5:3284. [PMID: 24518663 DOI: 10.1038/ncomms4284] [Cited by in Crossref: 181] [Cited by in F6Publishing: 191] [Article Influence: 25.9] [Reference Citation Analysis]
490 Steiner MA, Sciarretta C, Brisbare-Roch C, Strasser DS, Studer R, Jenck F. Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat. Psychoneuroendocrinology 2013;38:560-71. [PMID: 22917622 DOI: 10.1016/j.psyneuen.2012.07.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
491 Lang M, Söll RM, Dürrenberger F, Dautzenberg FM, Beck-sickinger AG. Structure−Activity Studies of Orexin A and Orexin B at the Human Orexin 1 and Orexin 2 Receptors Led to Orexin 2 Receptor Selective and Orexin 1 Receptor Preferring Ligands. J Med Chem 2004;47:1153-60. [DOI: 10.1021/jm030982t] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 2.9] [Reference Citation Analysis]
492 Suzuki H, Kubo Y, Yamamoto T. Orexin-A immunoreactive cells and fibers in the central nervous system of the axolotl brain and their association with tyrosine hydroxylase and serotonin immunoreactive somata. Journal of Chemical Neuroanatomy 2008;35:295-305. [DOI: 10.1016/j.jchemneu.2008.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
493 Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends in Neurosciences 2001;24:726-31. [DOI: 10.1016/s0166-2236(00)02002-6] [Cited by in Crossref: 1023] [Cited by in F6Publishing: 326] [Article Influence: 48.7] [Reference Citation Analysis]
494 Sun H, Kennedy WP, Wilbraham D, Lewis N, Calder N, Li X, Ma J, Yee KL, Ermlich S, Mangin E, Lines C, Rosen L, Chodakewitz J, Murphy GM. Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep 2013;36:259-67. [PMID: 23372274 DOI: 10.5665/sleep.2386] [Cited by in Crossref: 11] [Cited by in F6Publishing: 48] [Article Influence: 1.2] [Reference Citation Analysis]
495 Novak CM, Albers H. Localization of hypocretin-like immunoreactivity in the brain of the diurnal rodent, Arvicanthis niloticus. Journal of Chemical Neuroanatomy 2002;23:49-58. [DOI: 10.1016/s0891-0618(01)00144-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
496 Diniz GB, Candido PL, Klein MO, Alvisi RD, Presse F, Nahon J, Felicio LF, Bittencourt JC. The weaning period promotes alterations in the orexin neuronal population of rats in a suckling-dependent manner. Brain Struct Funct 2018;223:3739-55. [DOI: 10.1007/s00429-018-1723-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
497 Corcoran AE, Richerson GB, Harris MB. Functional link between the hypocretin and serotonin systems in the neural control of breathing and central chemosensitivity. J Neurophysiol 2015;114:381-9. [PMID: 25878157 DOI: 10.1152/jn.00870.2013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
498 Matsuzaki I, Sakurai T, Kunii K, Nakamura T, Yanagisawa M, Goto K. Involvement of the serotonergic system in orexin-induced behavioral alterations in rats. Regul Pept 2002;104:119-23. [PMID: 11830286 DOI: 10.1016/s0167-0115(01)00355-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
499 Hunt NJ, Waters KA, Machaalani R. Orexin receptors in the developing piglet hypothalamus, and effects of nicotine and intermittent hypercapnic hypoxia exposures. Brain Res 2013;1508:73-82. [PMID: 23500635 DOI: 10.1016/j.brainres.2013.03.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
500 Martins PJ, D'Almeida V, Pedrazzoli M, Lin L, Mignot E, Tufik S. Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regul Pept 2004;117:155-8. [PMID: 14749034 DOI: 10.1016/j.regpep.2003.10.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 3.8] [Reference Citation Analysis]
501 Tang H, Zhu Q, Li W, Qin S, Gong Y, Wang H, Shioda S, Li S, Huang J, Liu B, Fang Y, Liu Y, Wang S, Guo Y, Xia Q, Guo Y, Xu Z. Neurophysiology and Treatment of Disorders of Consciousness Induced by Traumatic Brain Injury: Orexin Signaling as a Potential Therapeutic Target. Curr Pharm Des 2019;25:4208-20. [PMID: 31663471 DOI: 10.2174/1381612825666191029101830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
502 Wu M, Zhang Z, Leranth C, Xu C, van den Pol AN, Alreja M. Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition. J Neurosci 2002;22:7754-65. [PMID: 12196599 [PMID: 12196599 DOI: 10.1523/jneurosci.22-17-07754.2002] [Cited by in Crossref: 83] [Article Influence: 4.2] [Reference Citation Analysis]
503 Torterolo P, Chase MH. The hypocretins (orexins) mediate the "phasic" components of REM sleep: A new hypothesis. Sleep Sci 2014;7:19-29. [PMID: 26483897 DOI: 10.1016/j.slsci.2014.07.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
504 Kim J, Nakajima K, Oomura Y, Wayner MJ, Sasaki K. Orexin-A and ghrelin depolarize the same pedunculopontine tegmental neurons in rats: An in vitro study. Peptides 2009;30:1328-35. [DOI: 10.1016/j.peptides.2009.03.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
505 Guillaumin MCC, Burdakov D. Neuropeptides as Primary Mediators of Brain Circuit Connectivity. Front Neurosci 2021;15:644313. [PMID: 33776641 DOI: 10.3389/fnins.2021.644313] [Reference Citation Analysis]
506 Shahid IZ, Rahman AA, Pilowsky PM. Orexin and Central Regulation of Cardiorespiratory System. Sleep Hormones. Elsevier; 2012. pp. 159-84. [DOI: 10.1016/b978-0-12-394623-2.00009-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
507 Ferrucci M, Limanaqi F, Ryskalin L, Biagioni F, Busceti CL, Fornai F. The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation. Front Neuroanat 2019;13:48. [PMID: 31133823 DOI: 10.3389/fnana.2019.00048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
508 Kaminski T, Smolinska N. Expression of orexin receptors in the pituitary. Vitam Horm 2012;89:61-73. [PMID: 22640608 DOI: 10.1016/B978-0-12-394623-2.00004-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
509 Kotz CM, Teske JA, Billington CJ. Neuroregulation of nonexercise activity thermogenesis and obesity resistance. Am J Physiol Regul Integr Comp Physiol 2008;294:R699-710. [PMID: 18160530 DOI: 10.1152/ajpregu.00095.2007] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
510 Inagawa Y, Shimizu S, Takenoshita N, Tsugawa A, Hirose D, Kanbayashi T, Imanishi A, Sakurai H, Hanyu H, Kanetaka H, Hirao K. Association between cerebrospinal fluid Orexin A level and severity of rapid eye movement sleep behaviour disorder in dementia with Lewy bodies. Psychogeriatrics 2021;21:128-30. [PMID: 33145889 DOI: 10.1111/psyg.12618] [Reference Citation Analysis]
511 Alexandre C, Andermann ML, Scammell TE. Control of arousal by the orexin neurons. Curr Opin Neurobiol 2013;23:752-9. [PMID: 23683477 DOI: 10.1016/j.conb.2013.04.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 8.0] [Reference Citation Analysis]
512 Saper CB, Fuller PM, Pedersen NP, Lu J, Scammell TE. Sleep state switching. Neuron 2010;68:1023-42. [PMID: 21172606 DOI: 10.1016/j.neuron.2010.11.032] [Cited by in Crossref: 775] [Cited by in F6Publishing: 639] [Article Influence: 70.5] [Reference Citation Analysis]
513 Smale L, Nunez AA, Schwartz MD. Rhythms in a diurnal brain. Biological Rhythm Research 2008;39:305-18. [DOI: 10.1080/09291010701682666] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
514 Schwartz MD, Kilduff TS. The Neurobiology of Sleep and Wakefulness. Psychiatr Clin North Am 2015;38:615-44. [PMID: 26600100 DOI: 10.1016/j.psc.2015.07.002] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
515 Liguori C, Mercuri NB, Nuccetelli M, Izzi F, Bernardini S, Placidi F, Ferini-strambi L. Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer’s Disease Patients Showing Neuropsychiatric Symptoms. JAD 2018;66:993-9. [DOI: 10.3233/jad-180769] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
516 Enrique Martínez-rodríguez J, Iranzo Á, Santamaría J. Narcolepsia. Medicina Clínica 2002;119:749-54. [DOI: 10.1016/s0025-7753(02)73563-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
517 Fujiki N, Yoshida Y, Ripley B, Honda K, Mignot E, Nishino S. Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 2001;12:993-7. [PMID: 11303775 DOI: 10.1097/00001756-200104170-00026] [Cited by in Crossref: 150] [Cited by in F6Publishing: 139] [Article Influence: 7.1] [Reference Citation Analysis]
518 Schmidt FM, Arendt E, Steinmetzer A, Bruegel M, Kratzsch J, Strauß M, Baum P, Hegerl U, Schönknecht P. CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls. Psychiatry Research 2011;190:240-3. [DOI: 10.1016/j.psychres.2011.06.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
519 Keenan RJ, Oberrauch S, Bron R, Nowell CJ, Challis LM, Hoyer D, Jacobson LH. Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510. J Alzheimers Dis 2021;79:693-708. [PMID: 33361602 DOI: 10.3233/JAD-201177] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
520 Kukkonen JP. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 2013;304:C2-32. [PMID: 23034387 DOI: 10.1152/ajpcell.00227.2012] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
521 Scammell TE. Wakefulness: an eye-opening perspective on orexin neurons. Curr Biol 2001;11:R769-71. [PMID: 11591333 DOI: 10.1016/s0960-9822(01)00466-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
522 Tortorella S, Rodrigo-Angulo ML, Núñez A, Garzón M. Synaptic interactions between perifornical lateral hypothalamic area, locus coeruleus nucleus and the oral pontine reticular nucleus are implicated in the stage succession during sleep-wakefulness cycle. Front Neurosci 2013;7:216. [PMID: 24311996 DOI: 10.3389/fnins.2013.00216] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
523 Bertucci JI, Blanco AM, Sundarrajan L, Rajeswari JJ, Velasco C, Unniappan S. Nutrient Regulation of Endocrine Factors Influencing Feeding and Growth in Fish. Front Endocrinol (Lausanne) 2019;10:83. [PMID: 30873115 DOI: 10.3389/fendo.2019.00083] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
524 Amador A, Wang Y, Banerjee S, Kameneka TM, Solt LA, Burris TP. Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression. PLoS One 2016;11:e0151014. [PMID: 26963516 DOI: 10.1371/journal.pone.0151014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
525 Mehta R, Khanday MA, Mallick BN. REM sleep loss associated changes in orexin-A levels in discrete brain areas in rats. Neurosci Lett 2015;590:62-7. [PMID: 25637698 DOI: 10.1016/j.neulet.2015.01.067] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
526 Miller JK, Miller BR, O'Neil DA, Yuste R. An increase in spontaneous activity mediates visual habituation. Cell Rep 2022;39:110751. [PMID: 35476991 DOI: 10.1016/j.celrep.2022.110751] [Reference Citation Analysis]
527 Mieda M, Tsujino N, Sakurai T. Differential roles of orexin receptors in the regulation of sleep/wakefulness. Front Endocrinol (Lausanne) 2013;4:57. [PMID: 23730297 DOI: 10.3389/fendo.2013.00057] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
528 Pałasz A, Lapray D, Peyron C, Rojczyk-Gołębiewska E, Skowronek R, Markowski G, Czajkowska B, Krzystanek M, Wiaderkiewicz R. Dual orexin receptor antagonists - promising agents in the treatment of sleep disorders. Int J Neuropsychopharmacol 2014;17:157-68. [PMID: 23702225 DOI: 10.1017/S1461145713000552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
529 Cid-pellitero ED, Garzón M. Hypocretin1/OrexinA-containing axons innervate locus coeruleus neurons that project to the Rat medial prefrontal cortex. Implication in the sleep-wakefulness cycle and cortical activation. Synapse 2011;65:843-57. [DOI: 10.1002/syn.20912] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
530 Bhagwandin A, Fuxe K, Bennett NC, Manger PR. Distribution of orexinergic neurons and their terminal networks in the brains of two species of African mole rats. Journal of Chemical Neuroanatomy 2011;41:32-42. [DOI: 10.1016/j.jchemneu.2010.11.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
531 Bettica P, Squassante L, Zamuner S, Nucci G, Danker-Hopfe H, Ratti E. The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia. Sleep 2012;35:1097-104. [PMID: 22851805 DOI: 10.5665/sleep.1996] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
532 Young JK, Wu M, Manaye KF, Kc P, Allard JS, Mack SO, Haxhiu MA. Orexin stimulates breathing via medullary and spinal pathways. Journal of Applied Physiology 2005;98:1387-95. [DOI: 10.1152/japplphysiol.00914.2004] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 6.2] [Reference Citation Analysis]
533 Levin BE. Central regulation of energy homeostasis intelligent design: how to build the perfect survivor. Obesity (Silver Spring) 2006;14 Suppl 5:192S-6S. [PMID: 17021365 DOI: 10.1038/oby.2006.307] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
534 López M, Tena-sempere M, García-caballero T, Señarís R, Diéguez C. Hypocretins in Endocrine Regulation. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 395-423. [DOI: 10.1007/0-387-25446-3_27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
535 Wang JB, Murata T, Narita K, Honda K, Higuchi T. Variation in the expression of orexin and orexin receptors in the rat hypothalamus during the estrous cycle, pregnancy, parturition, and lactation. Endocrine 2003;22:127-34. [PMID: 14665716 DOI: 10.1385/ENDO:22:2:127] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
536 Sakurai T. Orexin and Orexin Receptors. In: de Lecea L, Sutcliffe JG, editors. Hypocretins. Boston: Springer US; 2005. pp. 13-23. [DOI: 10.1007/0-387-25446-3_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
537 Duva MA, Tomkins EM, Moranda L, Kaplan R, Sukhaseum A, Bernardo JP, Stanley B. Regional differences in feeding and other behaviors elicited by N-methyl-d-aspartic acid in the rodent hypothalamus: a reverse microdialysis mapping study. Brain Research 2002;925:141-7. [DOI: 10.1016/s0006-8993(01)03269-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
538 España RA, Plahn S, Berridge CW. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res. 2002;943:224-236. [PMID: 12101045 DOI: 10.1016/S0006-8993(02)02653-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
539 Poli F, Plazzi G, Di Dalmazi G, Ribichini D, Vicennati V, Pizza F, Mignot E, Montagna P, Pasquali R, Pagotto U. Body mass index-independent metabolic alterations in narcolepsy with cataplexy. Sleep 2009;32:1491-7. [PMID: 19928388 DOI: 10.1093/sleep/32.11.1491] [Cited by in Crossref: 75] [Cited by in F6Publishing: 68] [Article Influence: 6.3] [Reference Citation Analysis]
540 Pérez-morales M, De La Herrán-arita AK, Méndez-díaz M, Ruiz-contreras AE, Drucker-colín R, Prospéro-garcía O. 2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. Pharmacology Biochemistry and Behavior 2013;108:1-7. [DOI: 10.1016/j.pbb.2013.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
541 Ohno K, Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol 2008;29:70-87. [PMID: 17910982 DOI: 10.1016/j.yfrne.2007.08.001] [Cited by in Crossref: 178] [Cited by in F6Publishing: 162] [Article Influence: 11.9] [Reference Citation Analysis]
542 Dye TJ, Simakajornboon N. Narcolepsy in Children: Sleep disorders in children, A rapidly evolving field seeking consensus. Pediatr Pulmonol 2021. [PMID: 34021733 DOI: 10.1002/ppul.25512] [Reference Citation Analysis]
543 Baumann CR, Bassetti CL. Hypocretins (orexins) and sleep–wake disorders. The Lancet Neurology 2005;4:673-82. [DOI: 10.1016/s1474-4422(05)70196-4] [Cited by in Crossref: 102] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
544 Osorio RS, Ducca EL, Wohlleber ME, Tanzi EB, Gumb T, Twumasi A, Tweardy S, Lewis C, Fischer E, Koushyk V, Cuartero-Toledo M, Sheikh MO, Pirraglia E, Zetterberg H, Blennow K, Lu SE, Mosconi L, Glodzik L, Schuetz S, Varga AW, Ayappa I, Rapoport DM, de Leon MJ. Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects. Sleep 2016;39:1253-60. [PMID: 26951396 DOI: 10.5665/sleep.5846] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
545 Nollet M, Gaillard P, Minier F, Tanti A, Belzung C, Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 2011;61:336-46. [PMID: 21530551 DOI: 10.1016/j.neuropharm.2011.04.022] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 6.4] [Reference Citation Analysis]
546 Sharf R, Sarhan M, Dileone RJ. Role of orexin/hypocretin in dependence and addiction. Brain Res 2010;1314:130-8. [PMID: 19699189 DOI: 10.1016/j.brainres.2009.08.028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 5.6] [Reference Citation Analysis]
547 Russell SH, Kim MS, Small CJ, Abbott CR, Morgan DGA, Taheri S, Murphy KG, Todd JF, Ghatei MA, Bloom SR. Central Administration of Orexin A Suppresses Basal and Domperidone Stimulated Plasma Prolactin: Orexin suppresses domperidone stimulated prolactin. Journal of Neuroendocrinology 2000;12:1213-8. [DOI: 10.1046/j.1365-2826.2000.00582.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
548 Ursin R. Serotonin and sleep. Sleep Medicine Reviews 2002;6:55-67. [DOI: 10.1053/smrv.2001.0174] [Cited by in Crossref: 191] [Cited by in F6Publishing: 151] [Article Influence: 9.6] [Reference Citation Analysis]
549 Bourgin P, Huitrón-Résendiz S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, de Lecea L. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 2000;20:7760-5. [PMID: 11027239 [PMID: 11027239 DOI: 10.1523/jneurosci.20-20-07760.2000] [Cited by in Crossref: 347] [Article Influence: 16.5] [Reference Citation Analysis]
550 Tose R, Kushikata T, Yoshida H, Kudo M, Furukawa K, Ueno S, Hirota K. Interaction between orexinergic neurons and NMDA receptors in the control of locus coeruleus-cerebrocortical noradrenergic activity of the rat. Brain Res 2009;1250:81-7. [PMID: 19007758 DOI: 10.1016/j.brainres.2008.10.041] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
551 Briggs C, Hirasawa M, Semba K. Sleep Deprivation Distinctly Alters Glutamate Transporter 1 Apposition and Excitatory Transmission to Orexin and MCH Neurons. J Neurosci 2018;38:2505-18. [PMID: 29431649 DOI: 10.1523/JNEUROSCI.2179-17.2018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
552 Xu Q, Wang DR, Dong H, Chen L, Lu J, Lazarus M, Cherasse Y, Chen GH, Qu WM, Huang ZL. Medial Parabrachial Nucleus Is Essential in Controlling Wakefulness in Rats. Front Neurosci 2021;15:645877. [PMID: 33841086 DOI: 10.3389/fnins.2021.645877] [Reference Citation Analysis]
553 Martins PJ, Marques MS, Tufik S, D'Almeida V. Orexin activation precedes increased NPY expression, hyperphagia, and metabolic changes in response to sleep deprivation. Am J Physiol Endocrinol Metab 2010;298:E726-34. [PMID: 20051529 DOI: 10.1152/ajpendo.00660.2009] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
554 Hoang QV, Bajic D, Yanagisawa M, Nakajima S, Nakajima Y. Effects of orexin (hypocretin) on GIRK channels. J Neurophysiol 2003;90:693-702. [PMID: 12702704 DOI: 10.1152/jn.00001.2003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 3.3] [Reference Citation Analysis]
555 Maehara S, Furukawa J, Ota T. Orexin 2 receptor is involved in orexin A-induced hyperlocomotion in rats. Pharmacol Rep 2019;71:1147-50. [PMID: 31655279 DOI: 10.1016/j.pharep.2019.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
556 Kotz CM, Teske JA, Levine JA, Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 2002;104:27-32. [PMID: 11830273 DOI: 10.1016/s0167-0115(01)00346-9] [Cited by in Crossref: 124] [Cited by in F6Publishing: 48] [Article Influence: 6.2] [Reference Citation Analysis]
557 Jöhren O, Gremmels JA, Qadri F, Dendorfer A, Dominiak P. Adrenal expression of orexin receptor subtypes is differentially regulated in experimental streptozotocin induced type-1 diabetes. Peptides 2006;27:2764-9. [DOI: 10.1016/j.peptides.2006.05.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
558 Davoudi M, Azizi H, Mirnajafi-zadeh J, Semnanian S. Decrease of inhibitory synaptic currents of locus coeruleus neurons via orexin type 1 receptors in the context of naloxone-induced morphine withdrawal. J Physiol Sci 2019;69:281-93. [DOI: 10.1007/s12576-018-0645-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
559 Mohammad-pour Kargar H, Azizi H, Mirnajafi-zadeh J, Ali Reza M, Semnanian S. Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors. Brain Research 2015;1624:424-32. [DOI: 10.1016/j.brainres.2015.07.050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
560 Hsu TM, Hahn JD, Konanur VR, Noble EE, Suarez AN, Thai J, Nakamoto EM, Kanoski SE. Hippocampus ghrelin signaling mediates appetite through lateral hypothalamic orexin pathways. Elife 2015;4:e11190. [PMID: 26745307 DOI: 10.7554/eLife.11190] [Cited by in Crossref: 61] [Cited by in F6Publishing: 36] [Article Influence: 8.7] [Reference Citation Analysis]
561 Ghaemi-jandabi M, Azizi H, Ahmadi-soleimani SM, Semnanian S. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats. Brain Research Bulletin 2017;130:107-11. [DOI: 10.1016/j.brainresbull.2017.01.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
562 Yoshimichi G, Yoshimatsu H, Masaki T, Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) 2001;226:468-76. [PMID: 11393177 DOI: 10.1177/153537020122600513] [Cited by in Crossref: 98] [Cited by in F6Publishing: 96] [Article Influence: 4.7] [Reference Citation Analysis]
563 Fenzl T, Romanowski CP, Flachskamm C, Deussing JM, Kimura M. Wake-promoting effects of orexin: Its independent actions against the background of an impaired corticotropine-releasing hormone receptor system. Behav Brain Res 2011;222:43-50. [PMID: 21420442 DOI: 10.1016/j.bbr.2011.03.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
564 Baumann CR, Bassetti CL. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter. Sleep Medicine Reviews 2005;9:253-68. [DOI: 10.1016/j.smrv.2005.01.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
565 Matsuura W, Nakamoto K, Tokuyama S. Involvement of descending pain control system regulated by orexin receptor signaling in the induction of central post-stroke pain in mice. Eur J Pharmacol 2020;874:173029. [PMID: 32084419 DOI: 10.1016/j.ejphar.2020.173029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
566 Sakamoto F, Yamada S, Ueta Y. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept 2004;118:183-91. [PMID: 15003835 DOI: 10.1016/j.regpep.2003.12.014] [Cited by in Crossref: 121] [Cited by in F6Publishing: 115] [Article Influence: 7.1] [Reference Citation Analysis]
567 Shono K, Yamamoto T. Orexin-2 receptors inhibit primary afferent fiber-evoked responses of ventral roots in the neonatal rat isolated spinal cord. Brain Research 2008;1218:97-102. [DOI: 10.1016/j.brainres.2008.04.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
568 Chung S, Civelli O. Orphan neuropeptides. Neuropeptides 2006;40:233-43. [DOI: 10.1016/j.npep.2006.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
569 Ripley B, Fujiki N, Okura M, Mignot E, Nishino S. Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol Dis 2001;8:525-34. [PMID: 11442359 DOI: 10.1006/nbdi.2001.0389] [Cited by in Crossref: 125] [Cited by in F6Publishing: 94] [Article Influence: 6.0] [Reference Citation Analysis]
570 Wu MF, John J, Maidment N, Lam HA, Siegel JM. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 2002;283:R1079-86. [PMID: 12376401 DOI: 10.1152/ajpregu.00207.2002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 4.4] [Reference Citation Analysis]
571 Kodama T, Kimura M. Arousal effects of orexin-A correlate with GLU release from the locus coeruleus in rats. Peptides 2002;23:1673-81. [DOI: 10.1016/s0196-9781(02)00109-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
572 Iyer M, Essner RA, Klingenberg B, Carter ME. Identification of discrete, intermingled hypocretin neuronal populations. J Comp Neurol 2018;526:2937-54. [PMID: 30019757 DOI: 10.1002/cne.24490] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
573 Zhang J, Sampogna S, Morales FR, Chase MH. Distribution of hypocretin (orexin) immunoreactivity in the feline pons and medulla. Brain Research 2004;995:205-17. [DOI: 10.1016/j.brainres.2003.10.004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
574 Kumamoto E. Cellular Mechanisms for Antinociception Produced by Oxytocin and Orexins in the Rat Spinal Lamina II-Comparison with Those of Other Endogenous Pain Modulators. Pharmaceuticals (Basel) 2019;12:E136. [PMID: 31527474 DOI: 10.3390/ph12030136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
575 Berridge CW, Waterhouse BD. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 2003;42:33-84. [PMID: 12668290 DOI: 10.1016/s0165-0173(03)00143-7] [Cited by in Crossref: 1455] [Cited by in F6Publishing: 690] [Article Influence: 76.6] [Reference Citation Analysis]
576 Nishino S, Fujiki N. Neuropeptides as possible targets in sleep disorders. Expert Opin Ther Targets 2007;11:37-59. [PMID: 17150033 DOI: 10.1517/14728222.11.1.37] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
577 Becchetti A. Neuronal nicotinic receptors in sleep-related epilepsy: studies in integrative biology. ISRN Biochem 2012;2012:262941. [PMID: 25969754 DOI: 10.5402/2012/262941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
578 Teske JA, Mavanji V. Energy expenditure: role of orexin. Vitam Horm 2012;89:91-109. [PMID: 22640610 DOI: 10.1016/B978-0-12-394623-2.00006-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
579 Haas HL, Lin J. Waking with the hypothalamus. Pflugers Arch - Eur J Physiol 2012;463:31-42. [DOI: 10.1007/s00424-011-0996-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
580 Choudhary RC, Khanday MA, Mitra A, Mallick BN. Perifornical orexinergic neurons modulate REM sleep by influencing locus coeruleus neurons in rats. Neuroscience. 2014;279:33-43. [PMID: 25168734 DOI: 10.1016/j.neuroscience.2014.08.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
581 Coborn JE, DePorter DP, Mavanji V, Sinton CM, Kotz CM, Billington CJ, Teske JA. Role of orexin-A in the ventrolateral preoptic area on components of total energy expenditure. Int J Obes (Lond) 2017;41:1256-62. [PMID: 28392556 DOI: 10.1038/ijo.2017.92] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
582 Russell SH, Small CJ, Dakin CL, Abbott CR, Morgan DGA, Ghatei MA, Bloom SR. The Central Effects of Orexin-A in the Hypothalamic-Pituitary-Adrenal Axis In Vivo and In Vitro in Male Rats: Effects of central orexin-A on CRF, ACTH and corticosterone release. Journal of Neuroendocrinology 2001;13:561-6. [DOI: 10.1046/j.1365-2826.2001.00672.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 80] [Article Influence: 4.1] [Reference Citation Analysis]
583 Dileone RJ, Georgescu D, Nestler EJ. Lateral hypothalamic neuropeptides in reward and drug addiction. Life Sciences 2003;73:759-68. [DOI: 10.1016/s0024-3205(03)00408-9] [Cited by in Crossref: 143] [Cited by in F6Publishing: 95] [Article Influence: 7.5] [Reference Citation Analysis]
584 Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanagisawa M, Nestler EJ, DiLeone RJ. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 2003;23:3106-11. [PMID: 12716916 [PMID: 12716916 DOI: 10.1523/jneurosci.23-08-03106.2003] [Cited by in Crossref: 250] [Article Influence: 13.2] [Reference Citation Analysis]
585 Pace-Schott EF, Hobson JA. The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci. 2002;3:591-605. [PMID: 12154361 DOI: 10.1038/nrn895] [Cited by in Crossref: 546] [Cited by in F6Publishing: 473] [Article Influence: 27.3] [Reference Citation Analysis]
586 Semjonous NM, Smith KL, Parkinson JR, Gunner DJ, Liu YL, Murphy KG, Ghatei MA, Bloom SR, Small CJ. Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int J Obes (Lond) 2009;33:775-85. [PMID: 19488048 DOI: 10.1038/ijo.2009.96] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
587 Pasumarthi RK, Fadel J. Activation of orexin/hypocretin projections to basal forebrain and paraventricular thalamus by acute nicotine. Brain Res Bull 2008;77:367-73. [PMID: 18950690 DOI: 10.1016/j.brainresbull.2008.09.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
588 Ferry B, Duchamp-Viret P. The orexin component of fasting triggers memory processes underlying conditioned food selection in the rat. Learn Mem 2014;21:185-9. [PMID: 24634353 DOI: 10.1101/lm.033688.113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
589 Ahmadi-soleimani SM, Mianbandi V, Azizi H, Azhdari-zarmehri H, Ghaemi-jandabi M, Abbasi-mazar A, Mohajer Y, Darana SP. Coregulation of sleep-pain physiological interplay by orexin system: An unprecedented review. Behavioural Brain Research 2020;391:112650. [DOI: 10.1016/j.bbr.2020.112650] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
590 España RA, Valentino RJ, Berridge CW. Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration. Neuroscience 2003;121:201-17. [PMID: 12946712 DOI: 10.1016/s0306-4522(03)00334-8] [Cited by in Crossref: 114] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
591 Yoshida Y, Fujiki N, Maki RA, Schwarz D, Nishino S. Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats. Neurosci Lett 2003;346:182-6. [PMID: 12853114 DOI: 10.1016/s0304-3940(03)00571-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
592 Peleg-Raibstein D, Burdakov D. Do orexin/hypocretin neurons signal stress or reward? Peptides 2021;145:170629. [PMID: 34416308 DOI: 10.1016/j.peptides.2021.170629] [Reference Citation Analysis]
593 Hoever P, Dorffner G, Beneš H, Penzel T, Danker-Hopfe H, Barbanoj MJ, Pillar G, Saletu B, Polo O, Kunz D, Zeitlhofer J, Berg S, Partinen M, Bassetti CL, Högl B, Ebrahim IO, Holsboer-Trachsler E, Bengtsson H, Peker Y, Hemmeter UM, Chiossi E, Hajak G, Dingemanse J. Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial. Clin Pharmacol Ther 2012;91:975-85. [PMID: 22549286 DOI: 10.1038/clpt.2011.370] [Cited by in Crossref: 93] [Cited by in F6Publishing: 88] [Article Influence: 9.3] [Reference Citation Analysis]
594 Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology. Pharmacol Rev 2012;64:389-420. [DOI: 10.1124/pr.111.005546] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 11.4] [Reference Citation Analysis]
595 Mieda M, Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status. CNS Drugs 2013;27:83-90. [PMID: 23359095 DOI: 10.1007/s40263-012-0036-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
596 Smith PM, Connolly BC, Ferguson AV. Microinjection of orexin into the rat nucleus tractus solitarius causes increases in blood pressure. Brain Res 2002;950:261-7. [PMID: 12231252 DOI: 10.1016/s0006-8993(02)03048-2] [Cited by in Crossref: 65] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
597 Li FW, Deurveilher S, Semba K. Behavioural and neuronal activation after microinjections of AMPA and NMDA into the perifornical lateral hypothalamus in rats. Behav Brain Res 2011;224:376-86. [PMID: 21723327 DOI: 10.1016/j.bbr.2011.06.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 0.6] [Reference Citation Analysis]
598 Assan D, Mustapha UF, Chen H, Li Z, Peng Y, Li G. The Roles of Neuropeptide Y (Npy) and Peptide YY (Pyy) in Teleost Food Intake: A Mini Review. Life (Basel) 2021;11:547. [PMID: 34200824 DOI: 10.3390/life11060547] [Reference Citation Analysis]
599 Stiasny-kolster K, Mignot E, Ling L, Möller J, Cassel W, Oertel W. CSF hypocretin-1 levels in restless legs syndrome. Neurology 2003;61:1426-9. [DOI: 10.1212/01.wnl.0000094196.50155.38] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
600 Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007;8:171-81. [DOI: 10.1038/nrn2092] [Cited by in Crossref: 763] [Cited by in F6Publishing: 716] [Article Influence: 50.9] [Reference Citation Analysis]
601 Xi M, Fung SJ, Yamuy J, Morales FR, Chase MH. Induction of Active (REM) Sleep and Motor Inhibition by Hypocretin in the Nucleus Pontis Oralis of the Cat. Journal of Neurophysiology 2002;87:2880-8. [DOI: 10.1152/jn.2002.87.6.2880] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.4] [Reference Citation Analysis]
602 Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, de Lecea L. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 2004;24:11439-48. [PMID: 15601950 DOI: 10.1523/JNEUROSCI.3459-04.2004] [Cited by in Crossref: 288] [Cited by in F6Publishing: 148] [Article Influence: 16.9] [Reference Citation Analysis]
603 Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 2006;148:752-9. [PMID: 16751790 DOI: 10.1038/sj.bjp.0706789] [Cited by in Crossref: 283] [Cited by in F6Publishing: 279] [Article Influence: 17.7] [Reference Citation Analysis]
604 Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun 2013;43:26-31. [PMID: 23497937 DOI: 10.1016/j.jaut.2013.02.003] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 7.3] [Reference Citation Analysis]
605 Fatemi I, Shamsizadeh A, Ayoobi F, Taghipour Z, Sanati MH, Roohbakhsh A, Motevalian M. Role of orexin-A in experimental autoimmune encephalomyelitis. J Neuroimmunol 2016;291:101-9. [PMID: 26857503 DOI: 10.1016/j.jneuroim.2016.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
606 Ikeda M, Hirono M, Sugiyama T, Moriya T, Ikeda-Sagara M, Eguchi N, Urade Y, Yoshioka T. Phospholipase C-beta4 is essential for the progression of the normal sleep sequence and ultradian body temperature rhythms in mice. PLoS One 2009;4:e7737. [PMID: 19898623 DOI: 10.1371/journal.pone.0007737] [Reference Citation Analysis]
607 Di Sebastiano AR, Yong-Yow S, Wagner L, Lehman MN, Coolen LM. Orexin mediates initiation of sexual behavior in sexually naive male rats, but is not critical for sexual performance. Horm Behav 2010;58:397-404. [PMID: 20541554 DOI: 10.1016/j.yhbeh.2010.06.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
608 Sakurai T. Orexin: a link between energy homeostasis and adaptive behaviour. Curr Opin Clin Nutr Metab Care. 2003;6:353-360. [PMID: 12806206 DOI: 10.1097/00075197-200307000-00001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
609 Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
610 Liu YP, Tung CS, Lin YL, Chuang CH. Wake-promoting agent modafinil worsened attentional performance following REM sleep deprivation in a young-adult rat model of 5-choice serial reaction time task. Psychopharmacology (Berl) 2011;213:155-66. [PMID: 20865249 DOI: 10.1007/s00213-010-2019-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
611 Wang C, Fujita T, Kumamoto E. Orexin B Modulates Spontaneous Excitatory and Inhibitory Transmission in Lamina II Neurons of Adult Rat Spinal Cord. Neuroscience 2018;383:114-28. [PMID: 29752983 DOI: 10.1016/j.neuroscience.2018.04.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
612 Deadwyler SA, Porrino L, Siegel JM, Hampson RE. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci 2007;27:14239-47. [PMID: 18160631 DOI: 10.1523/JNEUROSCI.3878-07.2007] [Cited by in Crossref: 186] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
613 Chrobok L, Palus-Chramiec K, Chrzanowska A, Kepczynski M, Lewandowski MH. Multiple excitatory actions of orexins upon thalamo-cortical neurons in dorsal lateral geniculate nucleus - implications for vision modulation by arousal. Sci Rep 2017;7:7713. [PMID: 28794459 DOI: 10.1038/s41598-017-08202-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
614 Katzman MA, Katzman MP. Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone. Brain Sciences 2022;12:150. [DOI: 10.3390/brainsci12020150] [Reference Citation Analysis]
615 Kilduff TS, Peyron C. The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disorders. Trends in Neurosciences 2000;23:359-65. [DOI: 10.1016/s0166-2236(00)01594-0] [Cited by in Crossref: 306] [Cited by in F6Publishing: 83] [Article Influence: 13.9] [Reference Citation Analysis]
616 Lin JS, Anaclet C, Sergeeva OA, Haas HL. The waking brain: an update. Cell Mol Life Sci 2011;68:2499-512. [PMID: 21318261 DOI: 10.1007/s00018-011-0631-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
617 Sterling ME, Chang GQ, Karatayev O, Chang SY, Leibowitz SF. Effects of embryonic ethanol exposure at low doses on neuronal development, voluntary ethanol consumption and related behaviors in larval and adult zebrafish: Role of hypothalamic orexigenic peptides. Behav Brain Res 2016;304:125-38. [PMID: 26778786 DOI: 10.1016/j.bbr.2016.01.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
618 Ross JA, Van Bockstaele EJ. The Locus Coeruleus- Norepinephrine System in Stress and Arousal: Unraveling Historical, Current, and Future Perspectives. Front Psychiatry 2020;11:601519. [PMID: 33584368 DOI: 10.3389/fpsyt.2020.601519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
619 Eacret D, Grafe LA, Dobkin J, Gotter AL, Renger JJ, Winrow CJ, Bhatnagar S. Orexin signaling during social defeat stress influences subsequent social interaction behaviour and recognition memory. Behavioural Brain Research 2019;356:444-52. [DOI: 10.1016/j.bbr.2018.05.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
620 Linehan V, Fang LZ, Parsons MP, Hirasawa M. High-fat diet induces time-dependent synaptic plasticity of the lateral hypothalamus. Mol Metab 2020;36:100977. [PMID: 32277924 DOI: 10.1016/j.molmet.2020.100977] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
621 Bettica P, Nucci G, Pyke C, Squassante L, Zamuner S, Ratti E, Gomeni R, Alexander R. Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist. J Psychopharmacol 2012;26:1058-70. [PMID: 21730017 DOI: 10.1177/0269881111408954] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
622 López M, Seoane LM, Tovar S, Nogueiras R, Diéguez C, Señarís R. Orexin-A regulates growth hormone-releasing hormone mRNA content in a nucleus-specific manner and somatostatin mRNA content in a growth hormone-dependent fashion in the rat hypothalamus. Eur J Neurosci 2004;19:2080-8. [PMID: 15090035 DOI: 10.1111/j.0953-816X.2004.03318.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
623 Volkoff H, Peter RE. Effects of CART peptides on food consumption, feeding and associated behaviors in the goldfish, Carassius auratus: actions on neuropeptide Y- and orexin A-induced feeding. Brain Research 2000;887:125-33. [DOI: 10.1016/s0006-8993(00)03001-8] [Cited by in Crossref: 112] [Cited by in F6Publishing: 17] [Article Influence: 5.1] [Reference Citation Analysis]
624 Rowe RK, Harrison JL, Morrison HW, Subbian V, Murphy SM, Lifshitz J. Acute Post-Traumatic Sleep May Define Vulnerability to a Second Traumatic Brain Injury in Mice. J Neurotrauma 2019;36:1318-34. [PMID: 30398389 DOI: 10.1089/neu.2018.5980] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
625 España RA, Berridge CW, Gammie SC. Diurnal levels of Fos immunoreactivity are elevated within hypocretin neurons in lactating mice. Peptides 2004;25:1927-34. [PMID: 15501524 DOI: 10.1016/j.peptides.2004.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
626 Shirasaka T, Miyahara S, Kunitake T, Jin QH, Kato K, Takasaki M, Kannan H. Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am J Physiol Regul Integr Comp Physiol 2001;281:R1114-8. [PMID: 11557617 DOI: 10.1152/ajpregu.2001.281.4.R1114] [Cited by in Crossref: 51] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
627 Chen C, Xu R. The In Vitro Regulation of Growth Hormone Secretion by Orexins. ENDO 2003;22:57-66. [DOI: 10.1385/endo:22:1:57] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
628 Tritos NA, Mastaitis JW, Kokkotou E, Maratos-flier E. Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus. Brain Research 2001;895:160-6. [DOI: 10.1016/s0006-8993(01)02066-2] [Cited by in Crossref: 75] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
629 Tran D, Bonaventure P, Hack M, Mirzadegan T, Dvorak C, Letavic M, Carruthers N, Lovenberg T, Sutton SW. Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists. European Journal of Pharmacology 2011;667:120-8. [DOI: 10.1016/j.ejphar.2011.05.074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
630 Acuna-Goycolea C, van den Pol A. Glucagon-like peptide 1 excites hypocretin/orexin neurons by direct and indirect mechanisms: implications for viscera-mediated arousal. J Neurosci 2004;24:8141-52. [PMID: 15371515 DOI: 10.1523/JNEUROSCI.1607-04.2004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 48] [Article Influence: 4.6] [Reference Citation Analysis]
631 Shigemoto Y, Fujii Y, Shinomiya K, Kamei C. Participation of histaminergic H1 and noradrenergic α1 receptors in orexin A-induced wakefulness in rats. Brain Research 2004;1023:121-5. [DOI: 10.1016/j.brainres.2004.07.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
632 Hunsley MS, Curtis WR, Palmiter RD. Behavioral and sleep/wake characteristics of mice lacking norepinephrine and hypocretin. Genes Brain Behav 2006;5:451-7. [DOI: 10.1111/j.1601-183x.2005.00179.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
633 Szentirmai É. Central but not systemic administration of ghrelin induces wakefulness in mice. PLoS One 2012;7:e41172. [PMID: 22815958 DOI: 10.1371/journal.pone.0041172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
634 Sharma R, Sahota P, Thakkar MM. Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus. J Pineal Res 2018;65:e12498. [DOI: 10.1111/jpi.12498] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
635 Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
636 Hooshmand B, Azizi H, Ahmadi-soleimani SM, Semnanian S. Synergistic effect of orexin-glutamate co-administration on spontaneous discharge rate of locus coeruleus neurons in morphine-dependent rats. Neuroscience Letters 2019;706:12-7. [DOI: 10.1016/j.neulet.2019.04.060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
637 Okamura N, Reinscheid RK. Neuropeptide S: A novel modulator of stress and arousal: Review. Stress 2009;10:221-6. [DOI: 10.1080/10253890701248673] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
638 Wright KP, Lowry CA, Lebourgeois MK. Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci 2012;5:50. [PMID: 22529774 DOI: 10.3389/fnmol.2012.00050] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
639 Sakurai T. Roles of orexins in the regulation of feeding and arousal. Sleep Medicine 2002;3:S3-9. [DOI: 10.1016/s1389-9457(02)00156-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
640 Brundin L, Petersén Å, Björkqvist M, Träskman-bendz L. Orexin and psychiatric symptoms in suicide attempters. Journal of Affective Disorders 2007;100:259-63. [DOI: 10.1016/j.jad.2006.10.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
641 Herring WJ, Roth T, Krystal AD, Michelson D. Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications. J Sleep Res 2018;28. [DOI: 10.1111/jsr.12782] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
642 González JA, Jensen LT, Fugger L, Burdakov D. Convergent inputs from electrically and topographically distinct orexin cells to locus coeruleus and ventral tegmental area. Eur J Neurosci 2012;35:1426-32. [PMID: 22507526 DOI: 10.1111/j.1460-9568.2012.08057.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
643 Li SB, de Lecea L. The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology 2020;167:107993. [PMID: 32135427 DOI: 10.1016/j.neuropharm.2020.107993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
644 Diniz Behn CG, Kopell N, Brown EN, Mochizuki T, Scammell TE. Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling. J Neurophysiol 2008;99:3090-103. [PMID: 18417630 DOI: 10.1152/jn.01243.2007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
645 Brown RE, Sergeeva OA, Eriksson KS, Haas HL. Convergent excitation of dorsal raphe serotonin neurons by multiple arousal systems (orexin/hypocretin, histamine and noradrenaline). J Neurosci 2002;22:8850-9. [PMID: 12388591 [PMID: 12388591 DOI: 10.1523/jneurosci.22-20-08850.2002] [Cited by in Crossref: 228] [Article Influence: 11.4] [Reference Citation Analysis]
646 León-domínguez U, Vela-bueno A, Froufé-torres M, León-carrión J. A chronometric functional sub-network in the thalamo-cortical system regulates the flow of neural information necessary for conscious cognitive processes. Neuropsychologia 2013;51:1336-49. [DOI: 10.1016/j.neuropsychologia.2013.03.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
647 D'Anna KL, Gammie SC. Hypocretin-1 dose-dependently modulates maternal behaviour in mice. J Neuroendocrinol 2006;18:553-66. [PMID: 16867176 DOI: 10.1111/j.1365-2826.2006.01448.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
648 Kilduff TS, De Lecea L. Mapping of the mRNAs for the hypocretin/orexin and melanin-concentrating hormone receptors: Networks of overlapping peptide systems. J Comp Neurol 2001;435:1-5. [DOI: 10.1002/cne.1189] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 3.0] [Reference Citation Analysis]
649 Niu J, Yokota S, Tsumori T, Qin Y, Yasui Y. Glutamatergic lateral parabrachial neurons innervate orexin-containing hypothalamic neurons in the rat. Brain Research 2010;1358:110-22. [DOI: 10.1016/j.brainres.2010.08.056] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
650 Berisha A, Shutkind K, Borniger JC. Sleep Disruption and Cancer: Chicken or the Egg? Front Neurosci 2022;16:856235. [DOI: 10.3389/fnins.2022.856235] [Reference Citation Analysis]
651 Grossberg AJ, Zhu X, Leinninger GM, Levasseur PR, Braun TP, Myers MG Jr, Marks DL. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci 2011;31:11376-86. [PMID: 21813697 DOI: 10.1523/JNEUROSCI.2311-11.2011] [Cited by in Crossref: 85] [Cited by in F6Publishing: 60] [Article Influence: 7.7] [Reference Citation Analysis]
652 Matsuo E, Mochizuki A, Nakayama K, Nakamura S, Yamamoto T, Shioda S, Sakurai T, Yanagisawa M, Shiuchi T, Minokoshi Y, Inoue T. Decreased Intake of Sucrose Solutions in Orexin Knockout Mice. J Mol Neurosci 2011;43:217-24. [DOI: 10.1007/s12031-010-9475-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
653 Schwartz MD, Smale L. Individual differences in rhythms of behavioral sleep and its neural substrates in Nile grass rats. J Biol Rhythms 2005;20:526-37. [PMID: 16275771 DOI: 10.1177/0748730405280924] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
654 Suchecki D, Antunes J, Tufik S. Palatable solutions during paradoxical sleep deprivation: reduction of hypothalamic-pituitary-adrenal axis activity and lack of effect on energy imbalance. J Neuroendocrinol 2003;15:815-21. [PMID: 12899675 DOI: 10.1046/j.1365-2826.2003.01067.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
655 Kok SW, Roelfsema F, Overeem S, Lammers GJ, Frölich M, Meinders AE, Pijl H. Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab 2005;288:E892-9. [PMID: 15625087 DOI: 10.1152/ajpendo.00327.2004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
656 Ishizuka T, Murotani T, Yamatodani A. Action of Modafinil Through Histaminergic and Orexinergic Neurons. Sleep Hormones. Elsevier; 2012. pp. 259-78. [DOI: 10.1016/b978-0-12-394623-2.00014-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
657 Dickinson H, Walker DW, Castillo-melendez M. Onset of feeding at birth—Perinatal development of the hypothalamic mechanisms that induce appetite and feeding in the newborn. Neuroscience Letters 2008;436:1-6. [DOI: 10.1016/j.neulet.2007.12.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
658 Holland PR. Headache and sleep: shared pathophysiological mechanisms. Cephalalgia 2014;34:725-44. [PMID: 25053747 DOI: 10.1177/0333102414541687] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 7.8] [Reference Citation Analysis]
659 Singh C, Oikonomou G, Prober DA. Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish. Elife 2015;4:e07000. [PMID: 26374985 DOI: 10.7554/eLife.07000] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 8.7] [Reference Citation Analysis]
660 Brunton PJ, Russell JA. Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats. J Neuroendocrinol 2003;15:633-7. [PMID: 12787047 DOI: 10.1046/j.1365-2826.2003.01045.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 2.5] [Reference Citation Analysis]
661 Berteotti C, Liguori C, Pace M. Dysregulation of the orexin/hypocretin system is not limited to narcolepsy but has far-reaching implications for neurological disorders. Eur J Neurosci 2021;53:1136-54. [PMID: 33290595 DOI: 10.1111/ejn.15077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
662 Nishino S. Hypothalamus, hypocretins/orexin, and vigilance control. Sleep Disorders. Elsevier; 2011. pp. 765-82. [DOI: 10.1016/b978-0-444-52007-4.00006-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
663 Huang H, Xu Y, van den Pol AN. Nicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences. J Neurophysiol 2011;106:1191-202. [PMID: 21653710 DOI: 10.1152/jn.00740.2010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 4.0] [Reference Citation Analysis]
664 Gompf HS, Aston-Jones G. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res 2008;1224:43-52. [PMID: 18614159 DOI: 10.1016/j.brainres.2008.05.060] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
665 Gerashchenko D, Kohls MD, Greco M, Waleh NS, Salin-Pascual R, Kilduff TS, Lappi DA, Shiromani PJ. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 2001;21:7273-83. [PMID: 11549737 [PMID: 11549737 DOI: 10.1523/jneurosci.21-18-07273.2001] [Cited by in Crossref: 165] [Cited by in F6Publishing: 1] [Article Influence: 7.9] [Reference Citation Analysis]
666 Hayatdavoudi P, Sadeghnia HR, Mohamadian-Roshan N, Hadjzadeh MA. Beneficial Effects of Selective Orexin-A Receptor Antagonist in 4-aminopyridine-induced Seizures in Male Rats. Adv Biomed Res 2017;6:162. [PMID: 29387673 DOI: 10.4103/abr.abr_262_16] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
667 Xu T, Yang Y, Ward R, Gao L, Liu Y. Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cellular Signalling 2013;25:2413-23. [DOI: 10.1016/j.cellsig.2013.07.025] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 7.6] [Reference Citation Analysis]
668 Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-71. [PMID: 10766253 DOI: 10.1038/35007534] [Cited by in Crossref: 3867] [Cited by in F6Publishing: 3615] [Article Influence: 175.8] [Reference Citation Analysis]
669 Eriksson KS, Sergeeva O, Brown RE, Haas HL. Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci 2001;21:9273-9. [PMID: 11717361 [PMID: 11717361 DOI: 10.1523/jneurosci.21-23-09273.2001] [Cited by in Crossref: 348] [Article Influence: 17.4] [Reference Citation Analysis]
670 Patel AX, Miller SR, Nathan PJ, Kanakaraj P, Napolitano A, Lawrence P, Koch A, Bullmore ET. Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and alprazolam following insulin-induced hypoglycemia in humans. Psychopharmacology (Berl) 2014;231:3817-28. [PMID: 24770625 DOI: 10.1007/s00213-014-3520-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
671 Nuñez A, Moreno-balandrán ME, Rodrigo-angulo ML, Garzón M, De Andrés I. Relationship between the perifornical hypothalamic area and oral pontine reticular nucleus in the rat. Possible implication of the hypocretinergic projection in the control of rapid eye movement sleep. European Journal of Neuroscience 2006;24:2834-42. [DOI: 10.1111/j.1460-9568.2006.05159.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
672 Huang HP, Zhu FP, Chen XW, Xu ZQ, Zhang CX, Zhou Z. Physiology of quantal norepinephrine release from somatodendritic sites of neurons in locus coeruleus. Front Mol Neurosci 2012;5:29. [PMID: 22408604 DOI: 10.3389/fnmol.2012.00029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
673 España RA. Hypocretin/orexin involvement in reward and reinforcement. Vitam Horm 2012;89:185-208. [PMID: 22640614 DOI: 10.1016/B978-0-12-394623-2.00010-X] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
674 Suzuki M, Beuckmann CT, Shikata K, Ogura H, Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Research 2005;1044:116-21. [DOI: 10.1016/j.brainres.2005.03.002] [Cited by in Crossref: 112] [Cited by in F6Publishing: 105] [Article Influence: 6.6] [Reference Citation Analysis]
675 Arch J. Orexins, feeding and the big picture. Br J Nutr 2000;84:401-3. [DOI: 10.1017/s0007114500001707] [Cited by in Crossref: 16] [Article Influence: 1.1] [Reference Citation Analysis]
676 Mair RD, Zhang Y, Bailey KR, Toupin MM, Mair RG. Effects of clonidine in the locus coeruleus on prefrontal- and hippocampal-dependent measures of attention and memory in the rat. Psychopharmacology (Berl) 2005;181:280-8. [PMID: 15830223 DOI: 10.1007/s00213-005-2263-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
677 Chen XW, Mu Y, Huang HP, Guo N, Zhang B, Fan SY, Xiong JX, Wang SR, Xiong W, Huang W, Liu T, Zheng LH, Zhang CX, Li LH, Yu ZP, Hu ZA, Zhou Z. Hypocretin-1 potentiates NMDA receptor-mediated somatodendritic secretion from locus ceruleus neurons. J Neurosci 2008;28:3202-8. [PMID: 18354023 DOI: 10.1523/JNEUROSCI.4426-07.2008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
678 Cai XJ, Liu XH, Evans M, Clapham JC, Wilson S, Arch JR, Morris R, Williams G. Orexins and feeding: special occasions or everyday occurrence? Regulatory Peptides 2002;104:1-9. [DOI: 10.1016/s0167-0115(01)00343-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
679 Hirota K, Kushikata T, Kudo M, Kudo T, Smart D, Matsuki A. Effects of central hypocretin-1 administration on hemodynamic responses in young-adult and middle-aged rats. Brain Res 2003;981:143-50. [PMID: 12885435 DOI: 10.1016/s0006-8993(03)03002-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
680 Hwang LL, Chen CT, Dun NJ. Mechanisms of orexin-induced depolarizations in rat dorsal motor nucleus of vagus neurones in vitro. J Physiol 2001;537:511-20. [PMID: 11731582 DOI: 10.1111/j.1469-7793.2001.00511.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
681 Vitiello B, Lederhendler I. Research on eating disorders: current status and future prospects. Biological Psychiatry 2000;47:777-86. [DOI: 10.1016/s0006-3223(99)00319-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
682 Wise A, Gearing K, Rees S. Target validation of G-protein coupled receptors. Drug Discov Today 2002;7:235-46. [PMID: 11839521 DOI: 10.1016/s1359-6446(01)02131-6] [Cited by in Crossref: 261] [Cited by in F6Publishing: 83] [Article Influence: 13.7] [Reference Citation Analysis]
683 Samson WK, Taylor MM. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am J Physiol Regul Integr Comp Physiol 2001;281:R1140-5. [PMID: 11557621 DOI: 10.1152/ajpregu.2001.281.4.R1140] [Cited by in Crossref: 45] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
684 López JM, Domínguez L, Moreno N, González A. Comparative immunohistochemical analysis of the distribution of orexins (hypocretins) in the brain of amphibians. Peptides 2009;30:873-87. [DOI: 10.1016/j.peptides.2009.01.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
685 Akanmu MA, Honda K. Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats. Brain Research 2005;1048:138-45. [DOI: 10.1016/j.brainres.2005.04.064] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 3.1] [Reference Citation Analysis]
686 Xu Y, Jackson VR, Civelli O. Orphan G protein-coupled receptors and obesity. European Journal of Pharmacology 2004;500:243-53. [DOI: 10.1016/j.ejphar.2004.07.029] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
687 Mang GM, Dürst T, Bürki H, Imobersteg S, Abramowski D, Schuepbach E, Hoyer D, Fendt M, Gee CE. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors. Sleep 2012;35:1625-35. [PMID: 23204605 DOI: 10.5665/sleep.2232] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
688 Heydendael W, Sengupta A, Beck S, Bhatnagar S. Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior. Physiol Behav 2014;130:182-90. [PMID: 24140988 DOI: 10.1016/j.physbeh.2013.10.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
689 Parekh B. Mechanisms of the blunting of the sympatho-adrenal response: a theory. Curr Diabetes Rev 2009;5:79-91. [PMID: 19442093 DOI: 10.2174/157339909788166846] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
690 Scammell TE, Winrow CJ. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011;51:243-66. [PMID: 21034217 DOI: